≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Abscess of Bartholin gland

DOID EFO Endpoint Browser PheWeb

N14_BARTHOABSCESS

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

only females

293145

2. Check conditions

None

293145

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — N75.1
  • Hospital discharge: ICD-9 — 6163A
  • Cause of death: ICD-10 — N75.1
  • Cause of death: ICD-9 — 6163A

2 out of 7 registries used, show all original rules.

1141

4. Check minimum number of events

None

1141

5. Include endpoints

None

1141

6. Filter based on genotype QC (FinnGen only)

1090

Control definitions (FinnGen only)

Control exclude
N14_FEMALEGENINF

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
N75
Name in latin
Abscessus glandulae vestibularis majoris (Bartholini)

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 7335 7335 -
Only index persons 7152 7152 -
Unadjusted period prevalence (%)
Whole population 0.21 0.21 -
Only index persons 0.26 0.26 -
Median age at first event (years)
Whole population - 37.16 -
Only index persons - 37.02 -

-FinnGen-

Key figures

All Female Male
Number of individuals 1090 1090 -
Unadjusted period prevalence (%) 0.39 0.39 -
Median age at first event (years) 38.12 38.12 -

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1141
Matched controls
11410
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N75.0
ICD-10 Finland
Cyst of Bartholin gland
305.2
307.7
327
15
N75.1
ICD-10 Finland
Abscess of Bartholin gland
4181.3
307.7
1010
21
LFF00
NOMESCO Finland
Marsupialisation of Bartholin gland
4694.1
307.7
347
*
P01AB01
ATC
metronidazole; oral, rectal
6.2
175.9
851
3682
N75.8
ICD-10 Finland
Other diseases of Bartholin gland
323.8
167.6
166
6
6163A
ICD-9 Finland
Inflammatory disease of cervix, vagina and vulva, Abscess of Bartholin's gland
+∞
153.7
144
*
LFF96
NOMESCO Finland
Other operation on Bartholin gland
+∞
141.7
133
*
LFA00
NOMESCO Finland
Incision of vulva or perineum
57.3
123.8
70
13
LFF10
NOMESCO Finland
Excision of Bartholin gland
667.3
123.7
120
*
N76.4
ICD-10 Finland
Abscess of vulva
35.4
115.1
73
22
8473
FHL
Guinea pig or gland excision
593.2
110.8
108
*
TLW99
NOMESCO Finland
Other minor surgical procedure in gynaecology
8.0
64.0
90
121
J01DB01
ATC
cefalexin; oral
4.9
46.1
1067
8497
S10
ICPC
Boil/carbuncle
4.3
45.1
127
326
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.3
41.5
599
3695
N75.9
ICD-10 Finland
Disease of Bartholin gland, unspecified
79.9
41.2
46
6
N71.0
ICD-10 Finland
Acute inflammatory disease of uterus
9.0
39.9
50
58
K61.0
ICD-10 Finland
Anal abscess
7.4
32.0
47
66
LFB10
NOMESCO Finland
Excision of lesion of vulva or perineum
8.6
30.1
39
47
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
4.2
29.8
83
210
L02.8
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of other sites
5.5
26.1
51
96
62212
ICD-8 Finland
Infective diseases of uterus (except cervix), vagina and vulva, Bartholinitis acuta
+∞
23.0
22
*
6162A
ICD-9 Finland
Inflammatory disease of cervix, vagina and vulva, Cyst of Bartholin's gland
+∞
21.9
21
*
K60.3
ICD-10 Finland
Anal fistula
5.8
21.7
40
71
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
2.7
21.6
130
528
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
3.2
19.9
82
270
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
19.1
504
3526
ZXD05
NOMESCO Finland
Urgent procedure
1.8
18.8
388
2524
N73.9
ICD-10 Finland
Female pelvic inflammatory disease, unspecified
7.3
18.3
27
38
JHA00
NOMESCO Finland
Anal or perianal incision
6.2
18.2
31
51
N75
ICD-10 Finland
Diseases of Bartholin gland
67.7
17.8
20
*
J01FF01
ATC
clindamycin; systemic
1.8
15.4
307
1955
N02AX02
ATC
tramadol; systemic, rectal
1.7
15.2
427
2989
L02
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle
3.0
15.2
70
246
X16
ICPC
Vulval symptom/complaint
3.9
14.8
44
117
N70.1
ICD-10 Finland
Chronic salpingitis and oophoritis
151.9
14.5
15
*
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
4.1
14.3
39
97
J02AC01
ATC
fluconazole; systemic
1.6
14.3
591
4540
UJF30
NOMESCO Finland
Ileoscopy through colon
2.2
13.9
127
618
N90.7
ICD-10 Finland
Vulvar cyst
12.2
13.6
24
20
8471
FHL
Incision (and possible drainage)
141.6
13.5
14
*
J01DA01
ATC
[U] cefalexin
1.6
13.3
716
5824
J01MA02
ATC
ciprofloxacin; systemic
1.6
13.1
369
2566
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.1
12.9
128
643
N76.0
ICD-10 Finland
Acute vaginitis
2.1
11.9
119
600
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.6
11.9
371
2632
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
11.1
407
2988
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.8
11.0
195
1188
N06AX11
ATC
mirtazapine; oral
1.6
10.7
396
2908
N73.6
ICD-10 Finland
Female pelvic peritoneal adhesions
+∞
10.4
10
*
LEB20
NOMESCO Finland
Marsupialisation of vaginal cyst
32.8
10.3
13
*
A02BC02
ATC
pantoprazole; systemic
1.5
10.3
721
6045
LEF10
NOMESCO Finland
Colpoperineoplasty
9.7
10.3
20
21
X29
ICPC
Genital sympt/compl female other
3.3
10.1
37
114
D95
ICPC
Anal fissure/perianal abscess
4.9
10.0
22
46
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
9.9
256
1724
X01
ICPC
Genital pain female
3.9
9.7
28
73
N03AX16
ATC
[U] pregabalin
1.6
9.6
226
1487
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
9.5
184
1147
JHD33
NOMESCO Finland
Completing incision of fistula-in-ano
17.7
9.4
14
8
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.7
9.4
190
1200
R52.9
ICD-10 Finland
Pain, unspecified
1.9
9.2
121
672
WX702
NOMESCO Finland
Supraglottic ventilation device
2.2
9.1
74
344
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.5
9.0
56
231
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
9.0
458
3566
M54.5
ICD-10 Finland
Low back pain
1.5
8.9
444
3441
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
8.9
478
3759
J01AA02
ATC
doxycycline; systemic
1.5
8.7
842
7407
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.3
8.7
65
292
JN3AD
NOMESCO Finland
Abdominal CT examination
1.9
8.7
121
685
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.8
8.6
127
731
6146A
ICD-9 Finland
Inflammatory disease of ovary, Fallopian tube, pelvic cellular tissue and peritoneum, Pelvic peritoneal adhesions, female
+∞
8.3
8
*
62213
ICD-8 Finland
Infective diseases of uterus (except cervix), vagina and vulva, Bartholinitis chronica
+∞
8.3
8
*
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
10.8
8.3
15
14
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.6
8.2
201
1331
UJF32
NOMESCO Finland
Coloscopy
1.6
8.0
221
1507
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
7.9
607
5059
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.5
7.9
49
202
N76.8
ICD-10 Finland
Other specified inflammation of vagina and vulva
3.5
7.8
26
75
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.8
7.8
109
617
N07BA03
ATC
varenicline; oral
2.3
7.7
60
274
R52.2
ICD-10 Finland
Other chronic pain
2.4
7.7
50
211
LFW96
NOMESCO Finland
Other operation on vulva or perineum
18.5
7.6
11
6
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
7.5
218
1499
L03
ICPC
Low back symptom/complaint
1.5
7.5
359
2738
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
7.5
259
1851
L02.0
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of face
3.9
7.4
21
54
JFF10
NOMESCO Finland
Loop enterostomy
13.5
7.4
12
9
61208
ICD-8 Finland
Acute salpingitis and oophoritis, Alia definita
+∞
7.3
7
*
6140A
ICD-9 Finland
Inflammatory disease of ovary, Fallopian tube, pelvic cellular tissue and peritoneum, Acute salpingitis and oophoritis[S-O-ITIS ACUTA]
+∞
7.3
7
*
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.7
7.3
154
981
WX882
NOMESCO Finland
High dependency care
3.5
7.3
24
69
M79.6
ICD-10 Finland
Pain in limb
1.4
7.2
503
4098
X59
ICD-10 Finland
Exposure to unspecified factor
1.6
7.2
187
1252
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.9
7.1
90
493
Z09.9
ICD-10 Finland
Follow-up examination after unspecified treatment for other conditions
3.8
7.1
21
56
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
6.9
240
1715
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
13.9
6.9
11
8
G01AA10
ATC
clindamycin; vaginal
1.5
6.9
214
1493
J01MA12
ATC
levofloxacin; systemic
1.6
6.8
147
941
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
1.9
6.8
83
450
D11
ICPC
Diarrhoea
1.6
6.8
164
1081
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
3.9
6.7
19
49
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
6.7
197
1358
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.1
6.7
61
298
A07AA02
ATC
nystatin; oral
2.2
6.6
56
266
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
6.5
257
1882
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
6.5
224
1597
X99
ICPC
Genital disease female other
5.7
6.5
17
30
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
6.5
185
1267
SPAT1263
SPAT
Sampling
1.4
6.4
449
3640
P01
ICPC
Feeling anxious/nervous/tense
1.5
6.4
218
1549
N82.3
ICD-10 Finland
Fistula of vagina to large intestine
14.4
6.4
10
7
M03BC01
ATC
orphenadrine (citrate); systemic
1.5
6.4
261
1924
ULC02
NOMESCO Finland
Hysteroscopy
2.0
6.4
70
366
R11
ICD-10 Finland
Nausea and vomiting
1.8
6.4
102
602
M54.4
ICD-10 Finland
Lumbago with sciatica
1.5
6.4
209
1474
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.1
6.4
56
270
M03BX02
ATC
tizanidine; oral
1.4
6.3
715
6256
J01EA01
ATC
trimethoprim; systemic
1.4
6.3
314
2400
D10
ICPC
Vomiting
1.8
6.3
94
543
F10.09
ICD-10 Finland
Alcohol intoxication UNS
3.5
6.3
21
61
S06.0
ICD-10 Finland
Concussion
1.7
6.3
109
659
LEE20
NOMESCO Finland
Closure of urovaginal fistula using graft or flap
+∞
6.3
6
*
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.5
6.2
242
1765
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.5
6.2
181
1244
O04.9
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
1.6
6.2
146
956
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
3.2
6.2
23
72
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.6
6.1
137
885
P03
ICPC
Feeling depressed
1.6
6.1
159
1065
N02BE01
ATC
paracetamol; systemic, rectal
1.6
6.1
992
9235
D20
ICPC
Mouth/tongue/lip symptom/complaint
2.0
6.1
60
302
N72
ICD-10 Finland
Inflammatory disease of cervix uteri
12.6
6.1
10
8
J01FA10
ATC
azithromycin; systemic
1.4
6.1
709
6216

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Obstetrics / Gynecology
16 [38004461]
2.8e-01
6.3e-01
1.7e+00
8.3e+00
3.0e+00
1.4e+00
9.5e-01
cases:36.79%
controls:30.56%
cases:20.65%
controls:12.20%
cases:11.63%
controls:2.37%
cases:81.88%
controls:0.11%
cases:32.28%
controls:2.22%
cases:34.81%
controls:11.86%
cases:50.56%
controls:28.37%
408
3372
701
7662
229
1346
880
9688
129
262
980
10772
908
12
201
11022
357
245
749
10771
376
1281
704
9516
496
2766
485
6985
metronidazole; oral, rectal
P01AB01 [21604857]
8.9e-01
1.6e+00
4.7e+00
1.0e+50
4.8e+00
1.8e+00
1.3e+00
cases:16.23%
controls:7.37%
cases:9.20%
controls:1.92%
cases:12.08%
controls:0.13%
cases:19.75%
controls:0.00%
cases:14.29%
controls:0.14%
cases:11.30%
controls:2.04%
cases:23.14%
controls:7.51%
180
813
929
10221
102
212
1007
10822
134
14
975
11020
219
0
890
11034
158
15
948
11001
122
220
958
10577
227
732
754
9019
cefalexin; oral
J01DB01 [21602870]
6.1e-01
1.2e+00
3.8e+00
—
3.6e+00
1.3e+00
9.7e-01
cases:39.22%
controls:25.98%
cases:22.00%
controls:8.14%
cases:24.44%
controls:0.73%
—
—
cases:21.97%
controls:0.80%
cases:24.07%
controls:8.21%
cases:48.62%
controls:26.45%
435
2867
674
8167
244
898
865
10136
271
81
838
10953
—
243
88
863
10928
260
886
820
9911
477
2579
504
7172
Bacteria identified in Isolate by Culture
43409-2 [3042936]
4.5e-01
1.5e+00
2.8e+00
1.0e+50
4.1e+00
1.1e+00
1.4e+00
cases:1.98%
controls:1.27%
cases:2.07%
controls:0.48%
cases:0.99%
controls:0.06%
cases:8.03%
controls:0.00%
cases:2.71%
controls:0.05%
cases:1.57%
controls:0.55%
cases:5.81%
controls:1.50%
22
140
1087
10894
23
53
1086
10981
11
7
1098
11027
89
0
1020
11034
30
5
1076
11011
17
59
1063
10738
57
146
924
9605
clindamycin; oral, parenteral
J01FF01 [21602985]
7.4e-01
8.7e-01
2.2e+00
—
3.5e+00
9.3e-01
8.9e-01
cases:5.23%
controls:2.56%
cases:1.71%
controls:0.73%
cases:0.90%
controls:0.10%
—
—
cases:1.45%
controls:0.05%
cases:1.57%
controls:0.63%
cases:6.42%
controls:2.74%
58
282
1051
10752
19
80
1090
10954
10
11
1099
11023
—
16
5
1090
11011
17
68
1063
10729
63
267
918
9484
Abscess of Bartholin gland
N75.1 [45587255]
3.0e+00
1.0e+50
1.0e+50
1.0e+50
1.0e+50
—
5.6e+00
cases:1.26%
controls:0.06%
cases:2.61%
controls:0.00%
cases:4.42%
controls:0.00%
cases:89.81%
controls:0.00%
cases:24.77%
controls:0.00%
—
—
cases:12.64%
controls:0.05%
14
7
1095
11027
29
0
1080
11034
49
0
1060
11034
996
0
113
11034
274
0
832
11016
—
124
5
857
9746
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
6.0e-01
1.1e+00
2.0e+00
—
2.7e+00
1.2e+00
9.2e-01
cases:6.13%
controls:3.47%
cases:2.61%
controls:0.86%
cases:0.90%
controls:0.12%
—
—
cases:1.63%
controls:0.11%
cases:2.87%
controls:0.92%
cases:7.95%
controls:3.31%
68
383
1041
10651
29
95
1080
10939
10
13
1099
11021
—
18
12
1088
11004
31
99
1049
10698
78
323
903
9428
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
1.6e-01
2.9e-01
9.9e-01
4.7e+00
1.4e+00
5.0e-01
3.7e-01
cases:37.06%
controls:33.49%
cases:19.93%
controls:15.63%
cases:5.23%
controls:2.01%
cases:5.86%
controls:0.05%
cases:7.32%
controls:2.01%
cases:23.06%
controls:15.35%
cases:47.50%
controls:38.45%
411
3695
698
7339
221
1725
888
9309
58
222
1051
10812
65
6
1044
11028
81
221
1025
10795
249
1657
831
9140
466
3749
515
6002
ibuprofen
R02AX02 [1588667]
1.6e-01
2.9e-01
9.9e-01
4.7e+00
1.4e+00
5.0e-01
3.7e-01
cases:37.06%
controls:33.49%
cases:19.93%
controls:15.63%
cases:5.23%
controls:2.01%
cases:5.86%
controls:0.05%
cases:7.32%
controls:2.01%
cases:23.06%
controls:15.35%
cases:47.50%
controls:38.45%
411
3695
698
7339
221
1725
888
9309
58
222
1051
10812
65
6
1044
11028
81
221
1025
10795
249
1657
831
9140
466
3749
515
6002
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
LC2BE [2001306544]
6.5e-01
8.5e-01
2.0e+00
—
2.2e+00
1.4e+00
1.0e+00
cases:11.72%
controls:6.49%
cases:5.50%
controls:2.43%
cases:1.71%
controls:0.24%
—
—
cases:3.16%
controls:0.35%
cases:7.87%
controls:2.15%
cases:15.80%
controls:6.27%
130
716
979
10318
61
268
1048
10766
19
26
1090
11008
—
35
39
1071
10977
85
232
995
10565
155
611
826
9140
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1.5e-01
2.9e-01
7.7e-01
4.8e+00
1.4e+00
3.3e-01
2.5e-01
cases:24.71%
controls:21.99%
cases:17.40%
controls:13.64%
cases:4.51%
controls:2.14%
cases:15.78%
controls:0.15%
cases:9.22%
controls:2.37%
cases:17.87%
controls:13.53%
cases:36.49%
controls:30.84%
274
2426
835
8608
193
1505
916
9529
50
236
1059
10798
175
17
934
11017
102
261
1004
10755
193
1461
887
9336
358
3007
623
6744
Pharmacy visit
OMOP4822462 [581458]
1.6e-01
5.2e-01
1.0e+00
3.6e+00
8.3e-01
5.6e-01
6.8e-01
cases:89.09%
controls:87.46%
cases:83.77%
controls:75.39%
cases:56.81%
controls:32.10%
cases:38.32%
controls:1.61%
cases:53.07%
controls:32.97%
cases:84.91%
controls:76.34%
cases:96.94%
controls:94.14%
988
9650
121
1384
929
8318
180
2716
630
3542
479
7492
425
178
684
10856
587
3632
519
7384
917
8242
163
2555
951
9180
30
571
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
2.6e-01
3.5e-01
9.7e-01
4.2e+00
1.2e+00
3.8e-01
4.8e-01
cases:15.51%
controls:12.43%
cases:8.21%
controls:5.92%
cases:2.07%
controls:0.80%
cases:3.07%
controls:0.05%
cases:2.80%
controls:0.84%
cases:8.06%
controls:5.66%
cases:22.73%
controls:15.41%
172
1372
937
9662
91
653
1018
10381
23
88
1086
10946
34
5
1075
11029
31
92
1075
10924
87
611
993
10186
223
1503
758
8248
Emergency Room Visit
ER [9203]
4.5e-01
6.8e-01
1.7e+00
—
2.3e+00
9.4e-01
7.7e-01
cases:38.68%
controls:28.71%
cases:17.04%
controls:9.43%
cases:5.68%
controls:1.06%
—
—
cases:10.04%
controls:1.09%
cases:20.19%
controls:8.98%
cases:42.92%
controls:25.77%
429
3168
680
7866
189
1040
920
9994
63
117
1046
10917
—
111
120
995
10896
218
970
862
9827
421
2513
560
7238
Medical doctor
Z2221 [2001311556]
6.1e-01
1.1e+00
1.3e+00
—
2.6e+00
1.4e+00
1.1e+00
cases:7.30%
controls:4.11%
cases:3.43%
controls:1.21%
cases:0.81%
controls:0.22%
—
—
cases:1.72%
controls:0.14%
cases:3.98%
controls:1.00%
cases:7.44%
controls:2.51%
81
453
1028
10581
38
134
1071
10900
9
24
1100
11010
—
19
15
1087
11001
43
108
1037
10689
73
245
908
9506
CBC panel - Blood by Automated count
58410-2 [40761511]
1.7e-01
1.2e-01
6.0e-01
4.6e+00
1.2e+00
1.7e-01
1.5e-01
cases:27.59%
controls:24.33%
cases:17.31%
controls:15.63%
cases:4.24%
controls:2.37%
cases:9.92%
controls:0.11%
cases:7.41%
controls:2.41%
cases:17.87%
controls:15.47%
cases:36.80%
controls:33.49%
306
2685
803
8349
192
1725
917
9309
47
261
1062
10773
110
12
999
11022
82
266
1024
10750
193
1670
887
9127
361
3266
620
6485
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
8.0e-02
9.1e-02
5.2e-01
4.4e+00
1.1e+00
3.2e-01
2.2e-01
cases:20.20%
controls:18.94%
cases:15.24%
controls:14.10%
cases:4.60%
controls:2.79%
cases:11.18%
controls:0.15%
cases:7.78%
controls:2.71%
cases:18.33%
controls:14.01%
cases:32.21%
controls:27.56%
224
2090
885
8944
169
1556
940
9478
51
308
1058
10726
124
17
985
11017
86
298
1020
10718
198
1513
882
9284
316
2687
665
7064
Leukocytes [#/volume] in Blood
26464-8 [3010813]
8.5e-02
6.8e-02
5.2e-01
4.4e+00
1.1e+00
2.6e-01
8.6e-02
cases:30.30%
controls:28.54%
cases:23.35%
controls:22.17%
cases:6.94%
controls:4.26%
cases:15.51%
controls:0.23%
cases:11.75%
controls:4.17%
cases:27.41%
controls:22.50%
cases:43.22%
controls:41.12%
336
3149
773
7885
259
2446
850
8588
77
470
1032
10564
172
25
937
11009
130
459
976
10557
296
2429
784
8368
424
4010
557
5741
fluconazole; oral, parenteral
J02AC01 [21603080]
4.7e-01
6.1e-01
1.8e+00
—
2.0e+00
6.9e-01
6.7e-01
cases:14.97%
controls:9.90%
cases:6.13%
controls:3.43%
cases:2.25%
controls:0.38%
—
—
cases:3.07%
controls:0.41%
cases:6.20%
controls:3.22%
cases:16.62%
controls:9.22%
166
1092
943
9942
68
378
1041
10656
25
42
1084
10992
—
34
45
1072
10971
67
348
1013
10449
163
899
818
8852
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
8.7e-02
6.0e-02
5.1e-01
4.4e+00
1.1e+00
2.7e-01
8.7e-02
cases:30.30%
controls:28.48%
cases:23.17%
controls:22.12%
cases:6.85%
controls:4.23%
cases:15.51%
controls:0.23%
cases:11.66%
controls:4.17%
cases:27.41%
controls:22.42%
cases:43.22%
controls:41.09%
336
3143
773
7891
257
2441
852
8593
76
467
1033
10567
172
25
937
11009
129
459
977
10557
296
2421
784
8376
424
4007
557
5744
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
9.1e-02
6.0e-02
5.1e-01
4.4e+00
1.1e+00
2.7e-01
8.7e-02
cases:30.39%
controls:28.49%
cases:23.17%
controls:22.13%
cases:6.85%
controls:4.24%
cases:15.51%
controls:0.23%
cases:11.66%
controls:4.17%
cases:27.50%
controls:22.49%
cases:43.22%
controls:41.09%
337
3144
772
7890
257
2442
852
8592
76
468
1033
10566
172
25
937
11009
129
459
977
10557
297
2428
783
8369
424
4007
557
5744
Platelets [#/volume] in Blood
26515-7 [3007461]
9.5e-02
5.8e-02
5.1e-01
4.4e+00
1.1e+00
2.7e-01
8.7e-02
cases:30.30%
controls:28.33%
cases:23.08%
controls:22.08%
cases:6.85%
controls:4.23%
cases:15.51%
controls:0.23%
cases:11.66%
controls:4.17%
cases:27.41%
controls:22.46%
cases:43.12%
controls:40.99%
336
3126
773
7908
256
2436
853
8598
76
467
1033
10567
172
25
937
11009
129
459
977
10557
296
2425
784
8372
423
3997
558
5754
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
8.8e-02
5.8e-02
5.1e-01
4.4e+00
1.1e+00
2.7e-01
8.7e-02
cases:30.30%
controls:28.48%
cases:23.17%
controls:22.16%
cases:6.85%
controls:4.24%
cases:15.51%
controls:0.23%
cases:11.66%
controls:4.18%
cases:27.50%
controls:22.49%
cases:43.22%
controls:41.09%
336
3142
773
7892
257
2445
852
8589
76
468
1033
10566
172
25
937
11009
129
460
977
10556
297
2428
783
8369
424
4007
557
5744
MCH [Entitic mass]
28539-5 [3035941]
8.9e-02
5.8e-02
5.1e-01
4.4e+00
1.1e+00
2.7e-01
8.8e-02
cases:30.30%
controls:28.45%
cases:23.17%
controls:22.15%
cases:6.85%
controls:4.24%
cases:15.51%
controls:0.23%
cases:11.66%
controls:4.18%
cases:27.41%
controls:22.46%
cases:43.22%
controls:41.07%
336
3139
773
7895
257
2444
852
8590
76
468
1033
10566
172
25
937
11009
129
460
977
10556
296
2425
784
8372
424
4005
557
5746
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
1.6e-01
3.3e-01
1.0e+00
3.7e+00
1.1e+00
3.7e-01
4.1e-01
cases:14.61%
controls:12.73%
cases:8.75%
controls:6.45%
cases:2.25%
controls:0.84%
cases:1.89%
controls:0.05%
cases:2.71%
controls:0.93%
cases:8.98%
controls:6.38%
cases:23.04%
controls:16.59%
162
1405
947
9629
97
712
1012
10322
25
93
1084
10941
21
5
1088
11029
30
102
1076
10914
97
689
983
10108
226
1618
755
8133
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
8.3e-02
5.4e-02
5.1e-01
4.4e+00
1.1e+00
2.7e-01
8.8e-02
cases:30.30%
controls:28.57%
cases:23.17%
controls:22.23%
cases:6.85%
controls:4.24%
cases:15.51%
controls:0.24%
cases:11.75%
controls:4.17%
cases:27.59%
controls:22.55%
cases:43.32%
controls:41.19%
336
3152
773
7882
257
2453
852
8581
76
468
1033
10566
172
26
937
11008
130
459
976
10557
298
2435
782
8362
425
4016
556
5735
Outpatient Visit
OP [9202]
2.1e-01
2.1e-01
3.2e-01
4.0e+00
1.1e+00
5.7e-01
5.0e-01
cases:68.26%
controls:63.53%
cases:44.45%
controls:39.46%
cases:11.72%
controls:8.75%
cases:20.20%
controls:0.46%
cases:22.97%
controls:9.00%
cases:52.87%
controls:38.75%
cases:78.49%
controls:68.97%
757
7010
352
4024
493
4354
616
6680
130
966
979
10068
224
51
885
10983
254
991
852
10025
571
4184
509
6613
770
6725
211
3026
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
2.1e-01
3.8e-01
5.8e-01
3.8e+00
1.1e+00
4.5e-01
3.8e-01
cases:28.13%
controls:24.13%
cases:16.68%
controls:12.00%
cases:2.80%
controls:1.58%
cases:3.07%
controls:0.07%
cases:4.70%
controls:1.67%
cases:17.31%
controls:11.79%
cases:38.74%
controls:30.24%
312
2663
797
8371
185
1324
924
9710
31
174
1078
10860
34
8
1075
11026
52
184
1054
10832
187
1273
893
9524
380
2949
601
6802
Ultrasound examination of uterus and parametria
LC2AE [2001306543]
7.4e-01
8.0e-01
—
—
2.7e+00
1.6e+00
8.3e-01
cases:3.34%
controls:1.62%
cases:1.44%
controls:0.65%
—
—
—
—
cases:0.81%
controls:0.05%
cases:1.85%
controls:0.40%
cases:3.67%
controls:1.63%
37
179
1072
10855
16
72
1093
10962
—
—
9
6
1097
11010
20
43
1060
10754
36
159
945
9592
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
5.3e-01
5.5e-01
1.3e+00
1.0e+50
1.7e+00
1.2e+00
9.7e-01
cases:7.48%
controls:4.54%
cases:2.98%
controls:1.74%
cases:0.99%
controls:0.27%
cases:0.54%
controls:0.00%
cases:1.36%
controls:0.26%
cases:4.91%
controls:1.53%
cases:11.93%
controls:4.87%
83
501
1026
10533
33
192
1076
10842
11
30
1098
11004
6
0
1103
11034
15
29
1091
10987
53
165
1027
10632
117
475
864
9276
One hour or less
ZXE00 [2001311394]
2.4e-01
2.5e-01
—
1.0e+50
3.5e+00
1.2e+00
8.6e-01
cases:7.21%
controls:5.76%
cases:1.89%
controls:1.48%
—
—
cases:5.23%
controls:0.00%
cases:2.44%
controls:0.07%
cases:4.91%
controls:1.46%
cases:8.56%
controls:3.79%
80
636
1029
10398
21
163
1088
10871
—
58
0
1051
11034
27
8
1079
11008
53
158
1027
10639
84
370
897
9381
Infection following a procedure, not elsewhere classified
T81.4 [45575538]
4.8e-01
—
—
—
2.5e+00
1.8e+00
1.3e+00
cases:1.17%
controls:0.73%
—
—
—
—
—
—
cases:0.54%
controls:0.05%
cases:1.20%
controls:0.19%
cases:2.45%
controls:0.71%
13
80
1096
10954
—
—
—
6
5
1100
11011
13
21
1067
10776
24
69
957
9682
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
2.1e-02
-2.4e-02
5.1e-01
4.4e+00
1.1e+00
1.3e-01
3.9e-02
cases:22.27%
controls:21.91%
cases:15.24%
controls:15.55%
cases:4.78%
controls:2.94%
cases:10.91%
controls:0.15%
cases:7.69%
controls:2.69%
cases:17.59%
controls:15.74%
cases:32.52%
controls:31.67%
247
2417
862
8617
169
1716
940
9318
53
324
1056
10710
121
16
988
11018
85
296
1021
10720
190
1699
890
9098
319
3088
662
6663
Boil/carbuncle
S10 [2002000975]
7.5e-01
2.2e+00
—
—
—
1.9e+00
1.4e+00
cases:0.90%
controls:0.43%
cases:1.08%
controls:0.12%
—
—
—
—
—
—
cases:0.83%
controls:0.13%
cases:2.04%
controls:0.50%
10
47
1099
10987
12
13
1097
11021
—
—
—
9
14
1071
10783
20
49
961
9702
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
7.2e-01
6.7e-01
—
—
2.6e+00
1.4e+00
7.2e-01
cases:2.61%
controls:1.30%
cases:0.90%
controls:0.46%
—
—
—
—
cases:0.63%
controls:0.05%
cases:1.57%
controls:0.41%
cases:3.98%
controls:1.97%
29
143
1080
10891
10
51
1099
10983
—
—
7
5
1099
11011
17
44
1063
10753
39
192
942
9559
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]
2.4e-01
9.4e-01
2.0e+00
—
1.7e+00
7.5e-01
2.2e-01
cases:9.47%
controls:7.59%
cases:5.05%
controls:2.03%
cases:2.16%
controls:0.29%
—
—
cases:1.45%
controls:0.26%
cases:4.44%
controls:2.15%
cases:10.40%
controls:8.50%
105
837
1004
10197
56
224
1053
10810
24
32
1085
11002
—
16
29
1090
10987
48
232
1032
10565
102
829
879
8922
General Practice
1 [38004446]
4.0e-01
7.0e-01
1.6e+00
—
1.4e+00
7.6e-01
6.1e-01
cases:11.81%
controls:8.27%
cases:5.23%
controls:2.67%
cases:1.71%
controls:0.36%
—
—
cases:1.27%
controls:0.33%
cases:5.09%
controls:2.45%
cases:14.07%
controls:8.15%
131
912
978
10122
58
295
1051
10739
19
40
1090
10994
—
14
36
1092
10980
55
265
1025
10532
138
795
843
8956
Laboratory Visit
OMOP4822461 [32036]
4.6e-02
1.2e-01
4.6e-01
4.1e+00
8.0e-01
2.1e-01
1.9e-02
cases:34.99%
controls:33.96%
cases:33.72%
controls:31.08%
cases:13.17%
controls:8.70%
cases:23.08%
controls:0.50%
cases:17.54%
controls:8.75%
cases:36.48%
controls:31.67%
cases:47.09%
controls:46.62%
388
3747
721
7287
374
3429
735
7605
146
960
963
10074
256
55
853
10979
194
964
912
10052
394
3419
686
7378
462
4546
519
5205
Gynecological ultrasound examination as part of clinical examination
LX1AE [2001306815]
1.9e-01
1.2e-01
1.7e+00
—
3.3e+00
1.1e+00
8.5e-01
cases:2.61%
controls:2.18%
cases:1.08%
controls:0.96%
cases:0.54%
controls:0.10%
—
—
cases:1.72%
controls:0.06%
cases:2.41%
controls:0.82%
cases:5.50%
controls:2.44%
29
240
1080
10794
12
106
1097
10928
6
11
1103
11023
—
19
7
1087
11009
26
89
1054
10708
54
238
927
9513
Cutaneous abscess, furuncle and carbuncle of other sites
L02.8 [45552968]
3.0e+00
—
1.0e+50
1.0e+50
—
—
2.1e+00
cases:0.90%
controls:0.05%
—
—
cases:0.54%
controls:0.00%
cases:0.63%
controls:0.00%
—
—
—
—
cases:1.02%
controls:0.12%
10
5
1099
11029
—
6
0
1103
11034
7
0
1102
11034
—
—
10
12
971
9739
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
1.7e-01
2.0e-01
4.6e-01
3.7e+00
8.9e-01
3.4e-01
2.4e-01
cases:16.77%
controls:14.48%
cases:12.44%
controls:10.39%
cases:2.71%
controls:1.73%
cases:3.25%
controls:0.08%
cases:4.43%
controls:1.87%
cases:14.63%
controls:10.85%
cases:29.05%
controls:24.38%
186
1598
923
9436
138
1146
971
9888
30
191
1079
10843
36
9
1073
11025
49
206
1057
10810
158
1172
922
9625
285
2377
696
7374
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
1.5e-01
1.7e-01
4.6e-01
3.9e+00
1.0e+00
2.4e-01
1.6e-01
cases:21.64%
controls:19.19%
cases:14.43%
controls:12.43%
cases:3.16%
controls:2.02%
cases:4.96%
controls:0.11%
cases:5.52%
controls:2.04%
cases:15.65%
controls:12.73%
cases:32.62%
controls:29.22%
240
2117
869
8917
160
1372
949
9662
35
223
1074
10811
55
12
1054
11022
61
225
1045
10791
169
1374
911
9423
320
2849
661
6902
Normoblasts [#/volume] in Blood
715-3 [3021589]
1.4e-01
1.8e-01
2.4e-01
3.4e+00
1.1e+00
3.7e-01
3.8e-01
cases:7.57%
controls:6.63%
cases:5.86%
controls:4.95%
cases:1.08%
controls:0.85%
cases:2.07%
controls:0.07%
cases:2.89%
controls:0.96%
cases:6.48%
controls:4.55%
cases:13.66%
controls:9.73%
84
732
1025
10302
65
546
1044
10488
12
94
1097
10940
23
8
1086
11026
32
106
1074
10910
70
491
1010
10306
134
949
847
8802
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
1.6e-01
1.5e-01
4.8e-01
3.9e+00
1.0e+00
2.3e-01
1.6e-01
cases:21.64%
controls:19.10%
cases:14.07%
controls:12.36%
cases:3.25%
controls:2.03%
cases:4.87%
controls:0.11%
cases:5.42%
controls:2.02%
cases:15.28%
controls:12.54%
cases:32.62%
controls:29.15%
240
2108
869
8926
156
1364
953
9670
36
224
1073
10810
54
12
1055
11022
60
223
1046
10793
165
1354
915
9443
320
2842
661
6909
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
1.0e-01
1.2e-01
3.8e-01
3.6e+00
8.8e-01
2.7e-01
1.2e-01
cases:23.90%
controls:22.07%
cases:17.58%
controls:15.93%
cases:3.97%
controls:2.74%
cases:5.14%
controls:0.15%
cases:6.51%
controls:2.81%
cases:20.09%
controls:16.14%
cases:36.29%
controls:33.48%
265
2435
844
8599
195
1758
914
9276
44
302
1065
10732
57
16
1052
11018
72
310
1034
10706
217
1743
863
9054
356
3265
625
6486
codeine and paracetamol
N02AJ06 [1123647]
4.2e-01
3.6e-01
9.0e-01
3.2e+00
8.2e-01
6.3e-01
4.9e-01
cases:13.89%
controls:9.58%
cases:4.96%
controls:3.50%
cases:1.26%
controls:0.52%
cases:1.35%
controls:0.05%
cases:1.36%
controls:0.60%
cases:6.02%
controls:3.30%
cases:16.21%
controls:10.63%
154
1057
955
9977
55
386
1054
10648
14
57
1095
10977
15
6
1094
11028
15
66
1091
10950
65
356
1015
10441
159
1037
822
8714
Case Management Agency
251B00000X [38004193]
2.9e-02
1.1e-01
5.7e-01
3.7e+00
4.9e-01
1.6e-01
4.7e-02
cases:52.39%
controls:51.68%
cases:47.88%
controls:45.08%
cases:28.76%
controls:18.65%
cases:30.39%
controls:1.09%
cases:27.22%
controls:18.64%
cases:50.65%
controls:46.57%
cases:62.59%
controls:61.49%
581
5702
528
5332
531
4974
578
6060
319
2058
790
8976
337
120
772
10914
301
2053
805
8963
547
5028
533
5769
614
5996
367
3755
Other specified counselling
Z71.8 [45581061]
4.8e-01
3.3e-01
1.6e+00
—
1.7e+00
6.1e-01
3.1e-01
cases:5.86%
controls:3.72%
cases:2.52%
controls:1.82%
cases:0.90%
controls:0.18%
—
—
cases:1.45%
controls:0.26%
cases:3.61%
controls:1.99%
cases:8.46%
controls:6.33%
65
411
1044
10623
28
201
1081
10833
10
20
1099
11014
—
16
29
1090
10987
39
215
1041
10582
83
617
898
9134
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
6.4e-01
4.0e-01
2.3e+00
—
—
1.3e+00
6.8e-01
cases:2.25%
controls:1.21%
cases:0.90%
controls:0.61%
cases:0.72%
controls:0.07%
—
—
—
—
cases:1.76%
controls:0.50%
cases:3.26%
controls:1.68%
25
133
1084
10901
10
67
1099
10967
8
8
1101
11026
—
—
19
54
1061
10743
32
164
949
9587
Follow-up examination after surgery for other conditions
Z09.0 [45576131]
3.9e-02
-1.0e+50
—
—
—
2.7e+00
1.4e+00
cases:0.63%
controls:0.61%
cases:0.00%
controls:0.15%
—
—
—
—
—
—
cases:2.41%
controls:0.16%
cases:2.14%
controls:0.54%
7
67
1102
10967
0
17
1109
11017
—
—
—
26
17
1054
10780
21
53
960
9698
Emergency Medicine
93 [38004510]
2.7e-01
4.2e-01
1.1e+00
—
2.0e+00
6.2e-01
4.5e-01
cases:11.81%
controls:9.27%
cases:6.58%
controls:4.41%
cases:1.98%
controls:0.67%
—
—
cases:3.89%
controls:0.57%
cases:8.15%
controls:4.57%
cases:22.32%
controls:15.43%
131
1023
978
10011
73
487
1036
10547
22
74
1087
10960
—
43
63
1063
10953
88
493
992
10304
219
1505
762
8246
clindamycin; vaginal
G01AA10 [21602372]
3.5e-01
4.7e-01
2.3e+00
—
—
8.9e-01
8.5e-01
cases:5.68%
controls:4.07%
cases:1.89%
controls:1.20%
cases:0.81%
controls:0.08%
—
—
—
—
cases:2.87%
controls:1.19%
cases:8.66%
controls:3.89%
63
449
1046
10585
21
132
1088
10902
9
9
1100
11025
—
—
31
129
1049
10668
85
379
896
9372
Supplier / Service Provider
OMOP5117446 [33004]
-1.0e+00
-1.0e+00
-5.8e-01
-1.0e+50
2.3e+00
2.8e+00
3.2e+00
cases:12.62%
controls:28.23%
cases:4.33%
controls:11.12%
cases:0.63%
controls:1.12%
cases:0.00%
controls:0.07%
cases:0.45%
controls:0.05%
cases:4.26%
controls:0.27%
cases:13.86%
controls:0.64%
140
3115
969
7919
48
1227
1061
9807
7
124
1102
10910
0
8
1109
11026
5
5
1101
11011
46
29
1034
10768
136
62
845
9689
Outpatient Hospital
22 [8756]
2.7e-01
2.6e-01
6.8e-01
—
1.9e+00
7.4e-01
7.6e-01
cases:25.79%
controls:20.96%
cases:7.66%
controls:6.04%
cases:1.44%
controls:0.73%
—
—
cases:4.07%
controls:0.61%
cases:10.83%
controls:5.50%
cases:30.38%
controls:16.90%
286
2313
823
8721
85
666
1024
10368
16
81
1093
10953
—
45
67
1061
10949
117
594
963
10203
298
1648
683
8103
Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
21416-3 [3003510]
3.6e-01
7.3e-01
9.6e-01
1.0e+50
1.4e+00
8.2e-01
6.5e-01
cases:7.03%
controls:5.03%
cases:3.79%
controls:1.86%
cases:0.54%
controls:0.21%
cases:1.62%
controls:0.00%
cases:0.90%
controls:0.22%
cases:3.61%
controls:1.63%
cases:9.48%
controls:5.20%
78
555
1031
10479
42
205
1067
10829
6
23
1103
11011
18
0
1091
11034
10
24
1096
10992
39
176
1041
10621
93
507
888
9244
Upper gastrointestinal surgery
106 [44777669]
5.6e-01
8.0e-01
9.5e-01
—
1.2e+00
1.3e+00
8.9e-01
cases:8.93%
controls:5.29%
cases:4.15%
controls:1.91%
cases:0.72%
controls:0.28%
—
—
cases:0.90%
controls:0.26%
cases:5.37%
controls:1.51%
cases:12.95%
controls:5.73%
99
584
1010
10450
46
211
1063
10823
8
31
1101
11003
—
10
29
1096
10987
58
163
1022
10634
127
559
854
9192
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
6.0e-02
-3.2e-01
1.3e+00
1.0e+50
2.1e+00
8.7e-01
5.4e-01
cases:3.07%
controls:2.89%
cases:0.99%
controls:1.36%
cases:0.54%
controls:0.15%
cases:1.98%
controls:0.00%
cases:0.99%
controls:0.12%
cases:2.59%
controls:1.10%
cases:6.73%
controls:4.05%
34
319
1075
10715
11
150
1098
10884
6
16
1103
11018
22
0
1087
11034
11
13
1095
11003
28
119
1052
10678
66
395
915
9356
Venereal disease screening
171128005 [4064905]
7.3e-01
2.2e+00
—
—
—
1.2e+00
1.2e+00
cases:1.53%
controls:0.74%
cases:1.35%
controls:0.15%
—
—
—
—
—
—
cases:0.65%
controls:0.19%
cases:1.94%
controls:0.56%
17
82
1092
10952
15
16
1094
11018
—
—
—
7
21
1073
10776
19
55
962
9696
Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6357-8 [3024950]
3.3e-01
7.1e-01
1.1e+00
1.0e+50
1.5e+00
7.5e-01
5.8e-01
cases:8.12%
controls:5.95%
cases:4.42%
controls:2.23%
cases:0.63%
controls:0.22%
cases:1.80%
controls:0.00%
cases:1.08%
controls:0.25%
cases:3.98%
controls:1.93%
cases:9.99%
controls:5.87%
90
656
1019
10378
49
246
1060
10788
7
24
1102
11010
20
0
1089
11034
12
28
1094
10988
43
208
1037
10589
98
572
883
9179
Bacteria identified in Urine by Culture
630-4 [3026008]
3.9e-01
5.6e-01
1.1e+00
2.9e+00
1.3e+00
3.5e-01
5.9e-01
cases:6.13%
controls:4.25%
cases:2.89%
controls:1.67%
cases:0.72%
controls:0.24%
cases:0.81%
controls:0.05%
cases:0.90%
controls:0.25%
cases:2.59%
controls:1.83%
cases:10.09%
controls:5.85%
68
469
1041
10565
32
184
1077
10850
8
26
1101
11008
9
5
1100
11029
10
28
1096
10988
28
198
1052
10599
99
570
882
9181
General anaesthesia
WX402 [2001310806]
1.1e-01
-4.9e-01
—
1.0e+50
2.6e+00
8.4e-01
8.7e-01
cases:1.80%
controls:1.62%
cases:0.45%
controls:0.73%
—
—
cases:0.81%
controls:0.00%
cases:1.18%
controls:0.09%
cases:1.39%
controls:0.60%
cases:5.61%
controls:2.43%
20
179
1089
10855
5
81
1104
10953
—
9
0
1100
11034
13
10
1093
11006
15
65
1065
10732
55
237
926
9514
lidocaine
C05AD01 [21601618]
3.8e-01
2.0e+00
—
—
—
1.6e+00
1.4e+00
cases:0.45%
controls:0.31%
cases:0.72%
controls:0.10%
—
—
—
—
—
—
cases:0.74%
controls:0.16%
cases:1.53%
controls:0.38%
5
34
1104
11000
8
11
1101
11023
—
—
—
8
17
1072
10780
15
37
966
9714
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
2.9e-01
-1.6e-01
1.2e+00
1.0e+50
2.0e+00
7.7e-01
6.4e-01
cases:5.68%
controls:4.33%
cases:1.71%
controls:2.00%
cases:0.63%
controls:0.19%
cases:2.71%
controls:0.00%
cases:0.90%
controls:0.13%
cases:3.33%
controls:1.57%
cases:9.48%
controls:5.21%
63
478
1046
10556
19
221
1090
10813
7
21
1102
11013
30
0
1079
11034
10
14
1096
11002
36
170
1044
10627
93
508
888
9243
Inpatient Hospital
21 [8717]
1.1e-01
2.0e-01
9.4e-01
—
1.4e+00
4.7e-01
5.8e-01
cases:33.63%
controls:31.29%
cases:11.72%
controls:9.82%
cases:2.71%
controls:1.08%
—
—
cases:3.80%
controls:0.98%
cases:13.70%
controls:9.06%
cases:38.94%
controls:26.22%
373
3452
736
7582
130
1083
979
9951
30
119
1079
10915
—
42
108
1064
10908
148
978
932
9819
382
2557
599
7194
lidocaine; ointment
D04AB01 [21602020]
3.5e-01
1.9e+00
—
—
—
1.6e+00
1.4e+00
cases:0.45%
controls:0.32%
cases:0.72%
controls:0.11%
—
—
—
—
—
—
cases:0.74%
controls:0.16%
cases:1.53%
controls:0.38%
5
35
1104
10999
8
12
1101
11022
—
—
—
8
17
1072
10780
15
37
966
9714
pivmecillinam; oral
J01CA08 [21602827]
2.6e-01
7.6e-01
1.4e+00
—
1.1e+00
5.7e-01
5.6e-01
cases:13.26%
controls:10.54%
cases:7.30%
controls:3.55%
cases:1.35%
controls:0.35%
—
—
cases:0.99%
controls:0.34%
cases:6.11%
controls:3.57%
cases:18.65%
controls:11.56%
147
1163
962
9871
81
392
1028
10642
15
39
1094
10995
—
11
38
1095
10978
66
385
1014
10412
183
1127
798
8624
Intravenous general anesthesia
WX404 [2001310807]
4.5e-01
3.1e-01
—
1.0e+50
—
1.8e+00
1.4e+00
cases:3.43%
controls:2.22%
cases:0.90%
controls:0.66%
—
—
cases:2.07%
controls:0.00%
—
—
cases:2.04%
controls:0.33%
cases:4.08%
controls:1.09%
38
245
1071
10789
10
73
1099
10961
—
23
0
1086
11034
—
22
36
1058
10761
40
106
941
9645
Tissue Pathology biopsy report
66121-5 [40768804]
2.4e-01
6.7e-01
8.5e-01
—
1.8e+00
6.4e-01
4.0e-01
cases:7.21%
controls:5.75%
cases:3.97%
controls:2.07%
cases:0.63%
controls:0.27%
—
—
cases:0.90%
controls:0.15%
cases:3.15%
controls:1.69%
cases:8.97%
controls:6.21%
80
635
1029
10399
44
228
1065
10806
7
30
1102
11004
—
10
16
1096
11000
34
182
1046
10615
88
606
893
9145
cefadroxil; oral
J01DB05 [21602874]
5.0e-01
5.8e-01
3.1e+00
—
—
—
6.7e-01
cases:2.98%
controls:1.82%
cases:0.63%
controls:0.35%
cases:0.99%
controls:0.05%
—
—
—
—
—
—
cases:2.45%
controls:1.26%
33
201
1076
10833
7
39
1102
10995
11
5
1098
11029
—
—
—
24
123
957
9628
Supraglottic ventilation device
WX702 [2001310818]
7.5e-01
—
—
1.0e+50
—
1.6e+00
1.4e+00
cases:0.63%
controls:0.30%
—
—
—
—
cases:1.17%
controls:0.00%
—
—
cases:0.74%
controls:0.15%
cases:1.63%
controls:0.39%
7
33
1102
11001
—
—
13
0
1096
11034
—
8
16
1072
10781
16
38
965
9713
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
2.8e-01
1.9e-01
2.1e-01
2.7e+00
7.1e-01
3.2e-01
3.8e-01
cases:11.54%
controls:8.97%
cases:6.49%
controls:5.42%
cases:1.44%
controls:1.17%
cases:0.90%
controls:0.06%
cases:2.44%
controls:1.22%
cases:6.76%
controls:5.02%
cases:17.02%
controls:12.35%
128
990
981
10044
72
598
1037
10436
16
129
1093
10905
10
7
1099
11027
27
134
1079
10882
73
542
1007
10255
167
1204
814
8547
Abscess of vulva
N76.4 [45558169]
—
1.0e+50
1.0e+50
1.0e+50
1.0e+50
—
3.0e+00
—
—
cases:0.63%
controls:0.00%
cases:0.45%
controls:0.00%
cases:1.71%
controls:0.00%
cases:1.08%
controls:0.00%
—
—
cases:1.43%
controls:0.07%
—
7
0
1102
11034
5
0
1104
11034
19
0
1090
11034
12
0
1094
11016
—
14
7
967
9744
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
1.4e-01
1.4e-01
1.1e+00
—
1.6e+00
8.2e-01
5.6e-01
cases:8.48%
controls:7.43%
cases:3.88%
controls:3.40%
cases:1.08%
controls:0.35%
—
—
cases:1.63%
controls:0.34%
cases:5.83%
controls:2.67%
cases:14.88%
controls:9.11%
94
820
1015
10214
43
375
1066
10659
12
39
1097
10995
—
18
37
1088
10979
63
288
1017
10509
146
888
835
8863
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
2.1e-01
5.4e-01
8.8e-01
—
1.5e+00
7.3e-01
7.2e-01
cases:4.42%
controls:3.61%
cases:2.61%
controls:1.54%
cases:0.63%
controls:0.26%
—
—
cases:0.81%
controls:0.18%
cases:3.15%
controls:1.54%
cases:9.07%
controls:4.65%
49
398
1060
10636
29
170
1080
10864
7
29
1102
11005
—
9
20
1097
10996
34
166
1046
10631
89
453
892
9298
Anal abscess
K61.0 [45601183]
—
—
—
1.0e+50
1.0e+50
2.9e+00
1.6e+00
—
—
—
—
—
—
cases:0.81%
controls:0.00%
cases:0.54%
controls:0.00%
cases:0.83%
controls:0.05%
cases:0.71%
controls:0.14%
—
—
—
9
0
1100
11034
6
0
1100
11016
9
5
1071
10792
7
14
974
9737
INR in Blood by Coagulation assay
34714-6 [3032080]
4.8e-01
6.4e-01
7.5e-01
—
1.3e+00
6.1e-01
4.4e-01
cases:5.77%
controls:3.65%
cases:3.61%
controls:1.93%
cases:0.90%
controls:0.43%
—
—
cases:1.63%
controls:0.44%
cases:3.15%
controls:1.74%
cases:8.15%
controls:5.39%
64
403
1045
10631
40
213
1069
10821
10
47
1099
10987
—
18
49
1088
10967
34
188
1046
10609
80
526
901
9225
Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
21613-5 [3006093]
4.3e-01
7.0e-01
1.7e+00
1.0e+50
1.5e+00
7.3e-01
6.7e-01
cases:4.96%
controls:3.30%
cases:2.71%
controls:1.37%
cases:0.63%
controls:0.12%
cases:2.34%
controls:0.00%
cases:0.90%
controls:0.21%
cases:2.41%
controls:1.18%
cases:7.95%
controls:4.25%
55
364
1054
10670
30
151
1079
10883
7
13
1102
11021
26
0
1083
11034
10
23
1096
10993
26
127
1054
10670
78
414
903
9337
General anesthesia, balanced
WX408 [2001310808]
6.1e-01
5.8e-01
-1.0e+50
1.0e+50
—
1.3e+00
9.6e-01
cases:4.15%
controls:2.30%
cases:1.35%
controls:0.76%
cases:0.00%
controls:0.09%
cases:1.53%
controls:0.00%
—
—
cases:1.67%
controls:0.48%
cases:3.98%
controls:1.56%
46
254
1063
10780
15
84
1094
10950
0
10
1109
11024
17
0
1092
11034
—
18
52
1062
10745
39
152
942
9599
Vulval symptom/complaint
X16 [2002001301]
—
2.8e+00
—
—
—
—
1.3e+00
—
—
cases:0.90%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.61%
controls:0.16%
—
10
6
1099
11028
—
—
—
—
6
16
975
9735
Anal fistula
K60.3 [45576995]
—
—
—
—
—
—
2.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.83%
controls:0.11%
—
—
—
—
—
—
18
11
963
9740
Gastroenterology
10 [38004455]
6.0e-01
7.8e-01
4.1e-01
—
6.9e-01
7.0e-01
6.9e-01
cases:5.50%
controls:3.08%
cases:3.52%
controls:1.65%
cases:0.45%
controls:0.30%
—
—
cases:0.54%
controls:0.27%
cases:2.87%
controls:1.44%
cases:8.05%
controls:4.20%
61
340
1048
10694
39
182
1070
10852
5
33
1104
11001
—
6
30
1100
10986
31
156
1049
10641
79
410
902
9341
Leukocytes [#/volume] in Urine
30405-5 [3018095]
2.2e-01
3.5e-01
9.2e-01
—
1.5e+00
6.4e-01
5.4e-01
cases:5.41%
controls:4.40%
cases:3.07%
controls:2.18%
cases:0.81%
controls:0.33%
—
—
cases:1.27%
controls:0.28%
cases:3.98%
controls:2.15%
cases:10.91%
controls:6.65%
60
485
1049
10549
34
241
1075
10793
9
36
1100
10998
—
14
31
1092
10985
43
232
1037
10565
107
648
874
9103
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
4.6e-01
6.8e-01
8.1e-01
—
1.1e+00
5.0e-01
3.9e-01
cases:7.03%
controls:4.56%
cases:4.24%
controls:2.20%
cases:0.81%
controls:0.36%
—
—
cases:1.27%
controls:0.41%
cases:3.80%
controls:2.33%
cases:9.68%
controls:6.79%
78
503
1031
10531
47
243
1062
10791
9
40
1100
10994
—
14
45
1092
10971
41
252
1039
10545
95
662
886
9089
Generalized anxiety disorder
F41.1 [45571764]
6.6e-01
4.4e-01
1.1e+00
—
1.6e+00
9.9e-01
5.8e-01
cases:1.62%
controls:0.84%
cases:0.81%
controls:0.53%
cases:0.45%
controls:0.15%
—
—
cases:0.72%
controls:0.15%
cases:1.48%
controls:0.56%
cases:2.45%
controls:1.38%
18
93
1091
10941
9
58
1100
10976
5
16
1104
11018
—
8
16
1098
11000
16
60
1064
10737
24
135
957
9616
varenicline; oral
N07BA03 [21604819]
1.1e+00
1.5e+00
—
—
—
—
1.4e+00
cases:1.26%
controls:0.41%
cases:0.63%
controls:0.14%
—
—
—
—
—
—
—
—
cases:1.63%
controls:0.39%
14
45
1095
10989
7
15
1102
11019
—
—
—
—
16
38
965
9713
Lump/swelling localized
S04 [2002000969]
7.1e-01
7.8e-01
2.6e+00
1.0e+50
—
9.0e-01
5.6e-01
cases:1.89%
controls:0.94%
cases:0.63%
controls:0.29%
cases:0.81%
controls:0.06%
cases:0.72%
controls:0.00%
—
—
cases:0.93%
controls:0.38%
cases:2.24%
controls:1.29%
21
104
1088
10930
7
32
1102
11002
9
7
1100
11027
8
0
1101
11034
—
10
41
1070
10756
22
126
959
9625
Correction of abdominal apron
QBJ30 [2001309871]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.61%
controls:0.05%
—
—
—
—
—
—
6
5
975
9746
Inflammatory disease of uterus, unspecified
N71.9 [45582420]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.61%
controls:0.05%
—
—
—
—
—
—
6
5
975
9746
High dependency care
WX882 [2001310847]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.61%
controls:0.05%
—
—
—
—
—
—
6
5
975
9746
Inhalation anesthesia
WX400 [2001310805]
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
cases:0.65%
controls:0.06%
—
—
—
—
—
—
—
7
6
1073
10791
—
Scheduled procedure
ZXD10 [2001311387]
3.7e-01
3.7e-01
—
1.0e+50
—
1.7e+00
7.6e-01
cases:6.31%
controls:4.46%
cases:1.80%
controls:1.25%
—
—
cases:0.54%
controls:0.00%
—
—
cases:4.81%
controls:0.93%
cases:6.32%
controls:3.05%
70
492
1039
10542
20
138
1089
10896
—
6
0
1103
11034
—
52
100
1028
10697
62
297
919
9454
estradiol; nasal, oral, parenteral, rectal, transdermal, vaginal
G03CA03 [21602517]
8.2e-02
2.0e-03
3.8e-01
2.4e+00
1.6e-01
2.0e-01
1.7e-01
cases:11.81%
controls:10.98%
cases:7.84%
controls:7.83%
cases:2.61%
controls:1.79%
cases:0.72%
controls:0.06%
cases:2.26%
controls:1.92%
cases:10.00%
controls:8.35%
cases:19.37%
controls:16.86%
131
1212
978
9822
87
864
1022
10170
29
198
1080
10836
8
7
1101
11027
25
212
1081
10804
108
902
972
9895
190
1644
791
8107
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1.4e-01
8.4e-02
3.7e-01
2.4e+00
4.9e-01
2.3e-01
1.2e-01
cases:23.99%
controls:21.52%
cases:15.96%
controls:14.86%
cases:3.61%
controls:2.52%
cases:0.90%
controls:0.08%
cases:4.07%
controls:2.52%
cases:18.06%
controls:14.84%
cases:35.68%
controls:33.02%
266
2375
843
8659
177
1640
932
9394
40
278
1069
10756
10
9
1099
11025
45
278
1061
10738
195
1602
885
9195
350
3220
631
6531
Emergency Room and Inpatient Visit
ERIP [262]
2.3e-01
4.5e-01
1.0e+00
—
1.9e+00
6.2e-01
4.4e-01
cases:3.88%
controls:3.12%
cases:2.16%
controls:1.40%
cases:0.45%
controls:0.16%
—
—
cases:1.18%
controls:0.17%
cases:2.41%
controls:1.32%
cases:9.07%
controls:6.04%
43
344
1066
10690
24
154
1085
10880
5
18
1104
11016
—
13
19
1093
10997
26
142
1054
10655
89
589
892
9162
More than one and less than three hours
ZXE10 [2001311401]
2.3e-01
5.3e-01
—
—
—
1.3e+00
9.9e-01
cases:4.87%
controls:3.92%
cases:1.80%
controls:1.07%
—
—
—
—
—
—
cases:2.41%
controls:0.66%
cases:6.01%
controls:2.32%
54
432
1055
10602
20
118
1089
10916
—
—
—
26
71
1054
10726
59
226
922
9525
Administrative procedure
-62 [2002000133]
2.3e+00
—
—
—
—
—
-1.0e+50
cases:0.63%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.10%
7
7
1102
11027
—
—
—
—
—
0
10
981
9741
Unspecified privation
X57 [45756410]
-1.0e+50
—
—
—
—
—
2.3e+00
cases:0.00%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
cases:0.71%
controls:0.07%
0
13
1109
11021
—
—
—
—
—
7
7
974
9744
Thorax extensive CT-examination
GD1BD [2001303621]
7.7e-01
—
—
—
—
—
2.3e+00
cases:0.45%
controls:0.21%
—
—
—
—
—
—
—
—
—
—
cases:0.71%
controls:0.07%
5
23
1104
11011
—
—
—
—
—
7
7
974
9744
Telehealth
OMOP5556618 [722455]
1.8e-01
1.9e-01
5.9e-01
2.2e+00
5.3e-01
2.2e-01
1.6e-01
cases:25.25%
controls:22.01%
cases:10.91%
controls:9.22%
cases:2.89%
controls:1.62%
cases:0.99%
controls:0.11%
cases:2.35%
controls:1.40%
cases:10.56%
controls:8.61%
cases:21.10%
controls:18.55%
280
2429
829
8605
121
1017
988
10017
32
179
1077
10855
11
12
1098
11022
26
154
1080
10862
114
930
966
9867
207
1809
774
7942
Follow-up examination after other treatment for other conditions
Z09.8 [45600303]
9.5e-01
—
—
—
—
2.2e+00
1.5e+00
cases:0.63%
controls:0.24%
—
—
—
—
—
—
—
—
cases:0.74%
controls:0.08%
cases:0.82%
controls:0.17%
7
27
1102
11007
—
—
—
—
8
9
1072
10788
8
17
973
9734
Other and unspecified abdominal pain
R10.4 [45568113]
4.6e-01
3.3e-01
—
—
1.2e+00
8.6e-01
8.6e-01
cases:8.57%
controls:5.56%
cases:2.34%
controls:1.70%
—
—
—
—
cases:0.63%
controls:0.19%
cases:3.15%
controls:1.36%
cases:12.23%
controls:5.57%
95
614
1014
10420
26
188
1083
10846
—
—
7
21
1099
10995
34
147
1046
10650
120
543
861
9208
Choriogonadotropin [Units/volume] in Serum or Plasma
19080-1 [3018171]
5.9e-01
8.7e-01
—
—
—
3.5e-01
7.0e-01
cases:3.88%
controls:2.19%
cases:1.71%
controls:0.73%
—
—
—
—
—
—
cases:1.11%
controls:0.79%
cases:5.20%
controls:2.66%
43
242
1066
10792
19
80
1090
10954
—
—
—
12
85
1068
10712
51
259
930
9492
Acute inflammatory disease of uterus
N71.0 [45596880]
1.5e+00
—
—
—
—
—
2.2e+00
cases:0.54%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
cases:1.22%
controls:0.14%
6
14
1103
11020
—
—
—
—
—
12
14
969
9737
Physiologic investigation of micturition
XKD06 [2001306098]
2.1e+00
—
—
—
—
—
—
cases:0.54%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
—
—
6
7
1103
11027
—
—
—
—
—
—
Destruction of endometrium
LCA16 [2001306554]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.61%
controls:0.07%
—
—
—
—
—
—
6
7
975
9744
Stenosis and insufficiency of lacrimal passages
H04.5 [45581556]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.61%
controls:0.07%
—
—
—
—
—
—
6
7
975
9744
Other obesity
E66.8 [45533036]
8.6e-01
1.2e+00
—
—
—
7.8e-01
9.2e-01
cases:1.53%
controls:0.65%
cases:1.08%
controls:0.33%
—
—
—
—
—
—
cases:0.93%
controls:0.43%
cases:2.04%
controls:0.82%
17
72
1092
10962
12
36
1097
10998
—
—
—
10
46
1070
10751
20
80
961
9671
Cutaneous abscess, furuncle and carbuncle
L02 [45538561]
8.1e-01
—
—
—
—
—
2.1e+00
cases:0.63%
controls:0.28%
—
—
—
—
—
—
—
—
—
—
cases:2.34%
controls:0.30%
7
31
1102
11003
—
—
—
—
—
23
29
958
9722
Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
18500-9 [3018006]
1.6e-01
4.4e-01
—
—
2.1e+00
6.5e-01
3.0e-01
cases:6.13%
controls:5.28%
cases:2.71%
controls:1.77%
—
—
—
—
cases:0.99%
controls:0.13%
cases:2.78%
controls:1.47%
cases:7.65%
controls:5.79%
68
583
1041
10451
30
195
1079
10839
—
—
11
14
1095
11002
30
159
1050
10638
75
565
906
9186
Cathetrisation of vein
TPH04 [2001309597]
5.9e-01
6.5e-01
—
1.0e+50
1.7e+00
1.1e+00
9.7e-01
cases:2.89%
controls:1.61%
cases:1.17%
controls:0.62%
—
—
cases:0.45%
controls:0.00%
cases:0.45%
controls:0.08%
cases:1.39%
controls:0.47%
cases:4.99%
controls:1.96%
32
178
1077
10856
13
68
1096
10966
—
5
0
1104
11034
5
9
1101
11007
15
51
1065
10746
49
191
932
9560
Urology
34 [38004474]
7.4e-01
9.8e-01
—
—
—
1.2e+00
8.1e-01
cases:1.89%
controls:0.92%
cases:1.08%
controls:0.41%
—
—
—
—
—
—
cases:1.39%
controls:0.41%
cases:2.45%
controls:1.11%
21
101
1088
10933
12
45
1097
10989
—
—
—
15
44
1065
10753
24
108
957
9643
Flexible sigmoidoscopy with biopsy
UJF45 [2001305031]
2.9e-01
—
—
—
—
2.0e+00
1.0e+00
cases:0.63%
controls:0.47%
—
—
—
—
—
—
—
—
cases:0.56%
controls:0.07%
cases:1.22%
controls:0.45%
7
52
1102
10982
—
—
—
—
6
8
1074
10789
12
44
969
9707
Medical abortion, complete or unspecified, complicated by delayed or excessive haemorrhage
O04.6 [45567881]
2.0e+00
—
—
—
—
—
—
cases:0.54%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
—
—
6
8
1103
11026
—
—
—
—
—
—
Evaluation of need for psychiatric rehabilitation
IBA02 [2001304044]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.61%
controls:0.08%
—
—
—
—
—
—
6
8
975
9743
Remote contact by phone
ZYC01 [2001311579]
1.9e+00
1.1e+00
—
—
—
6.3e-01
5.2e-01
cases:1.44%
controls:0.21%
cases:0.54%
controls:0.17%
—
—
—
—
—
—
cases:0.56%
controls:0.30%
cases:1.12%
controls:0.67%
16
23
1093
11011
6
19
1103
11015
—
—
—
6
32
1074
10765
11
65
970
9686
Bipolar affective disorder, current episode hypomanic
F31.0 [45542840]
1.9e+00
—
—
—
—
-1.0e+50
—
cases:0.72%
controls:0.11%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.05%
—
—
8
12
1101
11022
—
—
—
—
0
5
1080
10792
—
Other and unspecified ovarian cysts
N83.2 [45539066]
3.9e-01
1.5e-01
1.8e+00
—
—
1.2e+00
6.8e-01
cases:1.89%
controls:1.29%
cases:0.63%
controls:0.54%
cases:0.45%
controls:0.07%
—
—
—
—
cases:1.30%
controls:0.39%
cases:3.06%
controls:1.57%
21
142
1088
10892
7
60
1102
10974
5
8
1104
11026
—
—
14
42
1066
10755
30
153
951
9598
Other minor surgical procedure in gynaecology
TLW99 [2001306821]
9.7e-01
1.9e+00
—
1.0e+50
1.0e+50
—
1.9e+00
cases:0.45%
controls:0.17%
cases:0.54%
controls:0.08%
—
—
cases:2.71%
controls:0.00%
cases:1.63%
controls:0.00%
—
—
cases:1.12%
controls:0.17%
5
19
1104
11015
6
9
1103
11025
—
30
0
1079
11034
18
0
1088
11016
—
11
17
970
9734
Genital sympt/compl female other
X29 [2002001314]
1.3e+00
—
—
—
—
—
1.9e+00
cases:0.63%
controls:0.17%
—
—
—
—
—
—
—
—
—
—
cases:0.71%
controls:0.11%
7
19
1102
11015
—
—
—
—
—
7
11
974
9740
chlordiazepoxide; oral, parenteral
N05BA02 [21604567]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.71%
controls:0.11%
—
—
—
—
—
—
7
11
974
9740
buprenorphine; implant, parenteral, sublingual
N07BC01 [21604826]
—
-1.0e+50
—
—
—
-1.0e+50
1.8e+00
—
—
cases:0.00%
controls:0.05%
—
—
—
—
—
—
cases:0.00%
controls:0.07%
cases:0.82%
controls:0.13%
—
0
6
1109
11028
—
—
—
0
8
1080
10789
8
13
973
9738
Fear sexually transm dis female
X23 [2002001308]
7.5e-01
1.1e+00
—
—
—
6.2e-01
6.8e-01
cases:3.07%
controls:1.47%
cases:1.26%
controls:0.44%
—
—
—
—
—
—
cases:0.93%
controls:0.50%
cases:2.65%
controls:1.36%
34
162
1075
10872
14
49
1095
10985
—
—
—
10
54
1070
10743
26
133
955
9618
Haemorrhoids
K96 [2002000623]
1.8e+00
-1.0e+50
—
—
—
—
1.2e+00
cases:0.81%
controls:0.14%
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.71%
controls:0.22%
9
15
1100
11019
0
10
1109
11024
—
—
—
—
7
21
974
9730
Cutaneous abscess, furuncle and carbuncle, unspecified
L02.9 [45591620]
9.1e-01
—
—
1.0e+50
—
—
1.8e+00
cases:0.54%
controls:0.22%
—
—
—
—
cases:1.17%
controls:0.00%
—
—
—
—
cases:1.73%
controls:0.30%
6
24
1103
11010
—
—
13
0
1096
11034
—
—
17
29
964
9722
zopiclone; oral
N05CF01 [21604654]
5.2e-01
3.3e-01
5.3e-01
—
6.4e-01
7.2e-01
5.3e-01
cases:6.85%
controls:4.18%
cases:2.98%
controls:2.17%
cases:0.81%
controls:0.48%
—
—
cases:0.99%
controls:0.53%
cases:4.26%
controls:2.12%
cases:8.36%
controls:5.10%
76
461
1033
10573
33
239
1076
10795
9
53
1100
10981
—
11
58
1095
10958
46
229
1034
10568
82
497
899
9254
Dietary counselling and surveillance
Z71.3 [45552101]
9.4e-01
—
—
—
—
1.8e+00
2.4e-01
cases:1.17%
controls:0.46%
—
—
—
—
—
—
—
—
cases:0.65%
controls:0.11%
cases:0.71%
controls:0.56%
13
51
1096
10983
—
—
—
—
7
12
1073
10785
7
55
974
9696
Comprehensive monitoring of chronic illness
SPAT1250 [2001700351]
1.2e-01
5.6e-02
1.8e+00
—
—
4.9e-01
6.9e-02
cases:2.43%
controls:2.18%
cases:1.08%
controls:1.02%
cases:0.63%
controls:0.11%
—
—
—
—
cases:1.67%
controls:1.03%
cases:3.06%
controls:2.86%
27
240
1082
10794
12
113
1097
10921
7
12
1102
11022
—
—
18
111
1062
10686
30
279
951
9472
Dedicated profession-specific psychiatric intervention, group
IER02 [2001304206]
—
-1.0e+50
—
—
—
-1.0e+50
1.8e+00
—
—
cases:0.00%
controls:0.05%
—
—
—
—
—
—
cases:0.00%
controls:0.06%
cases:0.71%
controls:0.12%
—
0
5
1109
11029
—
—
—
0
6
1080
10791
7
12
974
9739
Urgent procedure
ZXD05 [2001311386]
2.8e-01
2.0e-01
—
1.0e+50
—
9.8e-01
7.6e-01
cases:5.23%
controls:3.99%
cases:1.35%
controls:1.11%
—
—
cases:6.67%
controls:0.00%
—
—
cases:2.41%
controls:0.92%
cases:6.73%
controls:3.25%
58
440
1051
10594
15
123
1094
10911
—
74
0
1035
11034
—
26
99
1054
10698
66
317
915
9434
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
C50.21 [2000500994]
—
—
—
—
—
2.1e+00
1.7e+00
—
—
—
—
—
—
—
—
—
—
cases:0.46%
controls:0.06%
cases:0.82%
controls:0.14%
—
—
—
—
—
5
6
1075
10791
8
14
973
9737
Psychiatric treatment plan, monitoring
ICB03 [2001304100]
1.5e+00
—
—
—
—
—
1.7e+00
cases:0.54%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
cases:0.82%
controls:0.14%
6
13
1103
11021
—
—
—
—
—
8
14
973
9737
2-person team, doctor-nurse
ZXY51 [2001311525]
1.7e+00
—
—
—
—
—
—
cases:0.81%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
—
9
16
1100
11018
—
—
—
—
—
—
Abdominal CT examination
JN3AD [2001305554]
1.4e+00
1.7e+00
—
—
—
—
8.6e-01
cases:0.81%
controls:0.20%
cases:0.72%
controls:0.14%
—
—
—
—
—
—
—
—
cases:1.63%
controls:0.70%
9
22
1100
11012
8
15
1101
11019
—
—
—
—
16
68
965
9683
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
3.8e-01
6.4e-01
6.3e-01
—
5.6e-01
3.7e-01
6.4e-01
cases:8.75%
controls:6.14%
cases:4.24%
controls:2.27%
cases:0.81%
controls:0.44%
—
—
cases:0.63%
controls:0.36%
cases:3.33%
controls:2.32%
cases:11.31%
controls:6.33%
97
677
1012
10357
47
251
1062
10783
9
48
1100
10986
—
7
40
1099
10976
36
251
1044
10546
111
617
870
9134
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
3.7e-01
2.8e-01
7.6e-03
—
9.0e-01
2.4e-01
3.6e-01
cases:9.92%
controls:7.07%
cases:5.50%
controls:4.22%
cases:0.72%
controls:0.72%
—
—
cases:1.99%
controls:0.82%
cases:4.81%
controls:3.83%
cases:13.76%
controls:9.98%
110
780
999
10254
61
466
1048
10568
8
79
1101
10955
—
22
90
1084
10926
52
414
1028
10383
135
973
846
8778
Nausea and vomiting
R11 [45539317]
7.1e-01
8.7e-01
—
—
-1.0e+50
1.6e+00
6.7e-01
cases:1.35%
controls:0.67%
cases:0.54%
controls:0.23%
—
—
—
—
cases:0.00%
controls:0.05%
cases:1.20%
controls:0.24%
cases:2.24%
controls:1.16%
15
74
1094
10960
6
25
1103
11009
—
—
0
5
1106
11011
13
26
1067
10771
22
113
959
9638
General Surgery
2 [38004447]
3.0e-01
3.6e-01
4.4e-01
—
4.1e-01
7.9e-01
5.2e-01
cases:17.13%
controls:13.25%
cases:5.50%
controls:3.89%
cases:0.81%
controls:0.53%
—
—
cases:0.90%
controls:0.60%
cases:7.50%
controls:3.54%
cases:18.04%
controls:11.58%
190
1462
919
9572
61
429
1048
10605
9
58
1100
10976
—
10
66
1096
10950
81
382
999
10415
177
1129
804
8622
Appendectomy
JEA00 [2001304802]
2.4e-01
—
—
—
—
—
1.6e+00
cases:0.45%
controls:0.35%
—
—
—
—
—
—
—
—
—
—
cases:1.22%
controls:0.25%
5
39
1104
10995
—
—
—
—
—
12
24
969
9727
Emotionally unstable personality disorder, impulsive
F60.30 [2000502022]
7.2e-01
1.6e+00
—
—
—
1.5e+00
1.1e+00
cases:0.72%
controls:0.35%
cases:0.81%
controls:0.16%
—
—
—
—
—
—
cases:0.74%
controls:0.17%
cases:1.22%
controls:0.42%
8
39
1101
10995
9
18
1100
11016
—
—
—
8
18
1072
10779
12
41
969
9710
Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
47845-3 [3048821]
—
-1.0e+50
—
—
—
—
1.6e+00
—
—
cases:0.00%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.92%
controls:0.18%
—
0
6
1109
11028
—
—
—
—
9
18
972
9733
buspirone; oral
N05BE01 [21604601]
7.3e-01
—
—
—
—
—
1.6e+00
cases:0.45%
controls:0.22%
—
—
—
—
—
—
—
—
—
—
cases:0.92%
controls:0.18%
5
24
1104
11010
—
—
—
—
—
9
18
972
9733
Joint symptom/complaint NOS
L20 [2002000644]
1.6e+00
—
—
—
—
-1.0e+50
8.5e-01
cases:0.72%
controls:0.15%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.06%
cases:0.71%
controls:0.31%
8
16
1101
11018
—
—
—
—
0
7
1080
10790
7
30
974
9721
Oxygen [Partial pressure] in Blood
11556-8 [3027315]
1.6e+00
—
—
—
—
—
—
cases:0.72%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
—
8
16
1101
11018
—
—
—
—
—
—
Base excess in Blood by calculation
11555-0 [3012501]
1.6e+00
—
—
—
—
—
—
cases:0.72%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
—
8
16
1101
11018
—
—
—
—
—
—
Carbon dioxide [Partial pressure] in Blood
11557-6 [3013290]
1.6e+00
—
—
—
—
—
—
cases:0.72%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
—
8
16
1101
11018
—
—
—
—
—
—
Psychiatry
26 [38004469]
5.0e-01
5.8e-01
4.8e-01
—
5.2e-01
5.2e-01
3.3e-01
cases:11.90%
controls:7.55%
cases:7.30%
controls:4.21%
cases:2.89%
controls:1.80%
—
—
cases:2.98%
controls:1.79%
cases:6.76%
controls:4.13%
cases:11.01%
controls:8.17%
132
833
977
10201
81
464
1028
10570
32
199
1077
10835
—
33
197
1073
10819
73
446
1007
10351
108
797
873
8954
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
1.7e-01
3.1e-01
1.1e+00
—
8.7e-01
4.6e-01
2.6e-01
cases:9.11%
controls:7.83%
cases:5.59%
controls:4.15%
cases:1.35%
controls:0.44%
—
—
cases:1.45%
controls:0.61%
cases:6.57%
controls:4.27%
cases:16.00%
controls:12.83%
101
864
1008
10170
62
458
1047
10576
15
48
1094
10986
—
16
67
1090
10949
71
461
1009
10336
157
1251
824
8500
Basophils/Leukocytes in Blood
30180-4 [3022096]
3.6e-01
2.8e-01
7.6e-03
—
8.7e-01
2.4e-01
3.6e-01
cases:9.83%
controls:7.06%
cases:5.50%
controls:4.23%
cases:0.72%
controls:0.72%
—
—
cases:1.99%
controls:0.84%
cases:4.81%
controls:3.84%
cases:13.76%
controls:10.02%
109
779
1000
10255
61
467
1048
10567
8
79
1101
10955
—
22
93
1084
10923
52
415
1028
10382
135
977
846
8774
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
1.5e-01
2.1e-01
—
—
1.4e+00
7.3e-01
8.5e-01
cases:3.61%
controls:3.12%
cases:1.71%
controls:1.40%
—
—
—
—
cases:0.54%
controls:0.14%
cases:2.78%
controls:1.35%
cases:8.46%
controls:3.79%
40
344
1069
10690
19
154
1090
10880
—
—
6
15
1100
11001
30
146
1050
10651
83
370
898
9381
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
1.9e-01
3.5e-01
1.1e+00
—
8.9e-01
4.6e-01
2.7e-01
cases:9.02%
controls:7.54%
cases:5.59%
controls:4.00%
cases:1.35%
controls:0.44%
—
—
cases:1.45%
controls:0.60%
cases:6.39%
controls:4.14%
cases:15.80%
controls:12.56%
100
832
1009
10202
62
441
1047
10593
15
49
1094
10985
—
16
66
1090
10950
69
447
1011
10350
155
1225
826
8526
Hyaline casts [#/volume] in Urine by Automated count
51484-4 [3030981]
6.7e-01
1.6e+00
—
—
—
8.7e-01
5.6e-01
cases:0.99%
controls:0.51%
cases:0.81%
controls:0.17%
—
—
—
—
—
—
cases:0.46%
controls:0.19%
cases:1.73%
controls:0.99%
11
56
1098
10978
9
19
1100
11015
—
—
—
5
21
1075
10776
17
97
964
9654
Spontaneous vertex delivery
O80.0 [45577661]
-2.8e-01
-2.3e-01
1.6e+00
—
-1.0e+50
-3.6e-01
6.9e-02
cases:6.40%
controls:8.30%
cases:1.89%
controls:2.37%
cases:0.81%
controls:0.17%
—
—
cases:0.00%
controls:0.22%
cases:1.67%
controls:2.38%
cases:8.05%
controls:7.56%
71
916
1038
10118
21
262
1088
10772
9
19
1100
11015
—
0
24
1106
10992
18
257
1062
10540
79
737
902
9014
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
1.6e+00
—
—
—
—
1.4e+00
5.0e-01
cases:1.98%
controls:0.43%
—
—
—
—
—
—
—
—
cases:0.46%
controls:0.11%
cases:1.22%
controls:0.75%
22
47
1087
10987
—
—
—
—
5
12
1075
10785
12
73
969
9678
hydrocortisone; local oral
A01AC03 [21600036]
-7.8e-02
—
—
—
—
1.5e+00
6.0e-01
cases:1.08%
controls:1.17%
—
—
—
—
—
—
—
—
cases:0.93%
controls:0.20%
cases:2.04%
controls:1.13%
12
129
1097
10905
—
—
—
—
10
22
1070
10775
20
110
961
9641
Pulpit UNS
K04.09 [2000502704]
1.5e+00
—
—
—
—
—
4.7e-01
cases:1.35%
controls:0.30%
—
—
—
—
—
—
—
—
—
—
cases:0.82%
controls:0.51%
15
33
1094
11001
—
—
—
—
—
8
50
973
9701
Endometriosis of uterus
N80.0 [45563025]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.02%
controls:0.23%
—
—
—
—
—
—
10
22
971
9729
Cutaneous abscess, furuncle and carbuncle of trunk
L02.2 [45586751]
1.3e+00
1.6e+00
—
1.0e+50
—
1.5e+00
1.5e+00
cases:0.90%
controls:0.25%
cases:0.45%
controls:0.09%
—
—
cases:0.45%
controls:0.00%
—
—
cases:0.56%
controls:0.13%
cases:1.83%
controls:0.41%
10
28
1099
11006
5
10
1104
11024
—
5
0
1104
11034
—
6
14
1074
10783
18
40
963
9711
Obesity due to excess calories
E66.01 [2000501501]
7.4e-01
2.5e-01
—
—
—
5.3e-01
7.5e-01
cases:2.52%
controls:1.22%
cases:0.81%
controls:0.63%
—
—
—
—
—
—
cases:1.11%
controls:0.66%
cases:3.47%
controls:1.67%
28
135
1081
10899
9
70
1100
10964
—
—
—
12
71
1068
10726
34
163
947
9588
Biopsy of vulva or perineum
LFB00 [2001306759]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.12%
controls:0.26%
—
—
—
—
—
—
11
25
970
9726
Other chronic pain
R52.2 [45568139]
—
1.6e+00
—
—
—
—
1.5e+00
—
—
cases:0.45%
controls:0.09%
—
—
—
—
—
—
—
—
cases:1.02%
controls:0.24%
—
5
10
1104
11024
—
—
—
—
10
23
971
9728
Paranasal sinuses X-ray examination in one projection
DM1QA [2001301761]
6.9e-01
—
—
—
—
—
1.5e+00
cases:0.45%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
cases:1.02%
controls:0.24%
5
25
1104
11009
—
—
—
—
—
10
23
971
9728
Insertion of intrauterine device
TLC00 [2001306647]
6.7e-01
—
—
—
—
1.4e+00
5.6e-01
cases:1.80%
controls:0.93%
—
—
—
—
—
—
—
—
cases:1.02%
controls:0.24%
cases:2.04%
controls:1.17%
20
103
1089
10931
—
—
—
—
11
26
1069
10771
20
114
961
9637
FEV1/FVC
19926-5 [3011505]
2.8e-01
2.8e-01
—
—
—
8.8e-01
1.4e+00
cases:1.35%
controls:1.02%
cases:0.54%
controls:0.41%
—
—
—
—
—
—
cases:0.65%
controls:0.27%
cases:2.65%
controls:0.64%
15
113
1094
10921
6
45
1103
10989
—
—
—
7
29
1073
10768
26
62
955
9689
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
2.8e-01
2.8e-01
—
—
—
8.8e-01
1.4e+00
cases:1.35%
controls:1.02%
cases:0.54%
controls:0.41%
—
—
—
—
—
—
cases:0.65%
controls:0.27%
cases:2.65%
controls:0.64%
15
113
1094
10921
6
45
1103
10989
—
—
—
7
29
1073
10768
26
62
955
9689
FEV1
20150-9 [3024653]
2.8e-01
2.8e-01
—
—
—
8.8e-01
1.4e+00
cases:1.35%
controls:1.02%
cases:0.54%
controls:0.41%
—
—
—
—
—
—
cases:0.65%
controls:0.27%
cases:2.65%
controls:0.64%
15
113
1094
10921
6
45
1103
10989
—
—
—
7
29
1073
10768
26
62
955
9689
Hidradenitis suppurativa
L73.2 [45557711]
1.5e+00
—
—
—
—
1.6e+00
1.4e+00
cases:0.54%
controls:0.13%
—
—
—
—
—
—
—
—
cases:0.46%
controls:0.09%
cases:1.12%
controls:0.27%
6
14
1103
11020
—
—
—
—
5
10
1075
10787
11
26
970
9725
FEV1 --post bronchodilation
20155-8 [3023550]
3.6e-01
—
—
—
—
6.6e-01
1.4e+00
cases:1.26%
controls:0.89%
—
—
—
—
—
—
—
—
cases:0.46%
controls:0.24%
cases:2.34%
controls:0.57%
14
98
1095
10936
—
—
—
—
5
26
1075
10771
23
56
958
9695
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
3.6e-01
—
—
—
—
6.6e-01
1.4e+00
cases:1.26%
controls:0.89%
—
—
—
—
—
—
—
—
cases:0.46%
controls:0.24%
cases:2.34%
controls:0.57%
14
98
1095
10936
—
—
—
—
5
26
1075
10771
23
56
958
9695
FEV1 percent change
69983-5 [42868472]
3.6e-01
—
—
—
—
6.6e-01
1.4e+00
cases:1.26%
controls:0.89%
—
—
—
—
—
—
—
—
cases:0.46%
controls:0.24%
cases:2.34%
controls:0.57%
14
98
1095
10936
—
—
—
—
5
26
1075
10771
23
56
958
9695
FEV1/FVC --post bronchodilation
69970-2 [42868459]
3.6e-01
—
—
—
—
6.6e-01
1.4e+00
cases:1.26%
controls:0.89%
—
—
—
—
—
—
—
—
cases:0.46%
controls:0.24%
cases:2.34%
controls:0.57%
14
98
1095
10936
—
—
—
—
5
26
1075
10771
23
56
958
9695
FVC percent change Respiratory system
69982-7 [42868471]
3.6e-01
—
—
—
—
6.6e-01
1.4e+00
cases:1.26%
controls:0.89%
—
—
—
—
—
—
—
—
cases:0.46%
controls:0.24%
cases:2.34%
controls:0.57%
14
98
1095
10936
—
—
—
—
5
26
1075
10771
23
56
958
9695
Dysuria
R30.0 [45592416]
—
—
—
—
—
—
1.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.22%
controls:0.30%
—
—
—
—
—
—
12
29
969
9722
Anxiety disorder/anxiety state
P74 [2002000868]
5.7e-01
1.0e+00
—
—
—
1.4e+00
7.1e-01
cases:1.08%
controls:0.62%
cases:0.54%
controls:0.20%
—
—
—
—
—
—
cases:1.11%
controls:0.28%
cases:1.53%
controls:0.76%
12
68
1097
10966
6
22
1103
11012
—
—
—
12
30
1068
10767
15
74
966
9677
dexrabeprazole
A02BC07 [45893509]
7.2e-01
1.4e+00
2.1e+00
—
—
1.1e+00
8.9e-01
cases:1.35%
controls:0.66%
cases:0.99%
controls:0.25%
cases:0.45%
controls:0.05%
—
—
—
—
cases:0.74%
controls:0.24%
cases:1.73%
controls:0.72%
15
73
1094
10961
11
28
1098
11006
5
6
1104
11028
—
—
8
26
1072
10771
17
70
964
9681
Psychiatric treatment plan, standard
ICB01 [2001304098]
1.4e+00
6.5e-01
—
—
—
8.4e-01
7.6e-01
cases:0.99%
controls:0.25%
cases:0.45%
controls:0.24%
—
—
—
—
—
—
cases:0.56%
controls:0.24%
cases:1.33%
controls:0.63%
11
28
1098
11006
5
26
1104
11008
—
—
—
6
26
1074
10771
13
61
968
9690
rabeprazole; oral
A02BC04 [21600099]
7.2e-01
1.4e+00
2.1e+00
—
—
1.1e+00
8.9e-01
cases:1.35%
controls:0.66%
cases:0.99%
controls:0.25%
cases:0.45%
controls:0.05%
—
—
—
—
cases:0.74%
controls:0.24%
cases:1.73%
controls:0.72%
15
73
1094
10961
11
28
1098
11006
5
6
1104
11028
—
—
8
26
1072
10771
17
70
964
9681
Poisoning by systemic antibiotics
T36 [45756588]
6.6e-01
—
—
—
—
—
1.4e+00
cases:1.08%
controls:0.56%
—
—
—
—
—
—
—
—
—
—
cases:1.63%
controls:0.42%
12
62
1097
10972
—
—
—
—
—
16
41
965
9710
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
2.5e-01
4.3e-01
5.8e-01
—
1.3e+00
6.8e-01
6.8e-01
cases:5.50%
controls:4.33%
cases:2.71%
controls:1.78%
cases:0.45%
controls:0.25%
—
—
cases:0.81%
controls:0.22%
cases:3.43%
controls:1.77%
cases:10.19%
controls:5.43%
61
478
1048
10556
30
196
1079
10838
5
28
1104
11006
—
9
24
1097
10992
37
191
1043
10606
100
529
881
9222
Urine symptom/complaint other
U07 [2002001142]
1.3e+00
—
—
—
—
—
1.2e-01
cases:0.99%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
cases:0.51%
controls:0.45%
11
29
1098
11005
—
—
—
—
—
5
44
976
9707
zolpidem; oral
N05CF02 [21604655]
4.6e-01
7.6e-01
4.4e-01
—
—
3.8e-01
5.7e-01
cases:3.79%
controls:2.43%
cases:2.52%
controls:1.20%
cases:0.45%
controls:0.29%
—
—
—
—
cases:1.94%
controls:1.33%
cases:4.69%
controls:2.71%
42
268
1067
10766
28
132
1081
10902
5
32
1104
11002
—
—
21
144
1059
10653
46
264
935
9487
loperamide oxide; oral
A07DA05 [21600648]
6.7e-01
8.9e-01
—
—
—
1.3e+00
7.7e-01
cases:1.26%
controls:0.65%
cases:0.81%
controls:0.34%
—
—
—
—
—
—
cases:1.11%
controls:0.30%
cases:1.83%
controls:0.86%
14
72
1095
10962
9
37
1100
10997
—
—
—
12
32
1068
10765
18
84
963
9667
loperamide; oral
A07DA03 [21600646]
6.7e-01
8.9e-01
—
—
—
1.3e+00
7.7e-01
cases:1.26%
controls:0.65%
cases:0.81%
controls:0.34%
—
—
—
—
—
—
cases:1.11%
controls:0.30%
cases:1.83%
controls:0.86%
14
72
1095
10962
9
37
1100
10997
—
—
—
12
32
1068
10765
18
84
963
9667
Orthopedic Surgery
20 [38004465]
4.6e-01
3.6e-01
3.5e-01
—
3.3e-01
5.2e-01
3.6e-01
cases:12.44%
controls:8.26%
cases:4.51%
controls:3.20%
cases:0.72%
controls:0.51%
—
—
cases:0.63%
controls:0.45%
cases:5.00%
controls:3.05%
cases:14.07%
controls:10.30%
138
911
971
10123
50
353
1059
10681
8
56
1101
10978
—
7
50
1099
10966
54
329
1026
10468
138
1004
843
8747
Procedure duration 90 to 119 minutes
ZXE13 [2001311404]
1.3e+00
—
—
—
—
-1.0e+50
9.1e-01
cases:1.35%
controls:0.36%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.15%
cases:0.71%
controls:0.29%
15
40
1094
10994
—
—
—
—
0
16
1080
10781
7
28
974
9723
Day surgery
ZXD20 [2001311388]
5.8e-01
—
—
—
—
1.3e+00
3.5e-01
cases:1.71%
controls:0.97%
—
—
—
—
—
—
—
—
cases:1.20%
controls:0.32%
cases:1.43%
controls:1.01%
19
107
1090
10927
—
—
—
—
13
35
1067
10762
14
98
967
9653
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
T81.0 [45599741]
8.8e-01
—
—
—
—
1.7e+00
1.3e+00
cases:0.63%
controls:0.26%
—
—
—
—
—
—
—
—
cases:0.56%
controls:0.10%
cases:1.43%
controls:0.39%
7
29
1102
11005
—
—
—
—
6
11
1074
10786
14
38
967
9713
Participation in compiling a psychiatric treatment plan
ICZ03 [2001304119]
1.3e+00
1.3e+00
—
—
—
8.2e-01
9.4e-01
cases:0.99%
controls:0.27%
cases:0.63%
controls:0.18%
—
—
—
—
—
—
cases:0.46%
controls:0.20%
cases:1.12%
controls:0.44%
11
30
1098
11004
7
20
1102
11014
—
—
—
5
22
1075
10775
11
43
970
9708
Laceration/cut
S18 [2002000983]
3.5e-01
8.5e-01
8.2e-01
—
—
4.4e-01
4.5e-01
cases:5.41%
controls:3.89%
cases:3.25%
controls:1.41%
cases:0.45%
controls:0.20%
—
—
—
—
cases:2.22%
controls:1.44%
cases:7.65%
controls:5.03%
60
429
1049
10605
36
156
1073
10878
5
22
1104
11012
—
—
24
155
1056
10642
75
490
906
9261
Gynaecological examination (general)(routine)
Z01.4 [45542395]
2.8e-01
6.5e-01
—
—
1.7e+00
8.0e-01
4.9e-01
cases:4.15%
controls:3.18%
cases:1.62%
controls:0.85%
—
—
—
—
cases:0.63%
controls:0.12%
cases:2.04%
controls:0.93%
cases:5.81%
controls:3.63%
46
351
1063
10683
18
94
1091
10940
—
—
7
13
1099
11003
22
100
1058
10697
57
354
924
9397
Irregular menstruation, unspecified
N92.6 [45539075]
3.1e-01
1.3e+00
—
—
—
5.4e-01
5.4e-01
cases:1.26%
controls:0.93%
cases:1.17%
controls:0.33%
—
—
—
—
—
—
cases:0.56%
controls:0.32%
cases:2.04%
controls:1.20%
14
103
1095
10931
13
36
1096
10998
—
—
—
6
35
1074
10762
20
117
961
9634
pregabalin; oral
N02BF02 [955152]
6.3e-01
5.2e-01
8.7e-01
—
6.2e-01
6.2e-01
6.6e-01
cases:4.69%
controls:2.56%
cases:2.16%
controls:1.30%
cases:0.90%
controls:0.38%
—
—
cases:0.72%
controls:0.39%
cases:2.04%
controls:1.10%
cases:4.99%
controls:2.66%
52
282
1057
10752
24
143
1085
10891
10
42
1099
10992
—
8
43
1098
10973
22
119
1058
10678
49
259
932
9492
Hysteroscopy
ULC02 [2001306644]
5.3e-01
—
—
—
—
—
1.3e+00
cases:0.63%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
cases:1.43%
controls:0.40%
7
41
1102
10993
—
—
—
—
—
14
39
967
9712
Monitoring of emergency patient
SPAT1104 [2001700205]
1.3e+00
1.5e+00
—
—
—
—
6.9e-01
cases:1.26%
controls:0.35%
cases:0.54%
controls:0.12%
—
—
—
—
—
—
—
—
cases:0.51%
controls:0.26%
14
39
1095
10995
6
13
1103
11021
—
—
—
—
5
25
976
9726
ispaghula (psylla seeds); oral
A06AC01 [21600555]
6.0e-01
3.8e-01
—
—
—
4.9e-01
6.7e-01
cases:3.88%
controls:2.16%
cases:1.44%
controls:0.99%
—
—
—
—
—
—
cases:1.76%
controls:1.08%
cases:5.40%
controls:2.83%
43
238
1066
10796
16
109
1093
10925
—
—
—
19
117
1061
10680
53
276
928
9475
Monocytes/Leukocytes in Blood
26485-3 [3019069]
3.5e-01
2.7e-01
7.6e-03
—
9.0e-01
2.2e-01
3.6e-01
cases:9.83%
controls:7.12%
cases:5.50%
controls:4.25%
cases:0.72%
controls:0.72%
—
—
cases:1.99%
controls:0.82%
cases:4.72%
controls:3.83%
cases:13.66%
controls:9.90%
109
786
1000
10248
61
469
1048
10565
8
79
1101
10955
—
22
90
1084
10926
51
413
1029
10384
134
965
847
8786
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
3.3e-01
2.2e-01
-5.1e-03
—
8.8e-01
2.1e-01
3.5e-01
cases:10.19%
controls:7.57%
cases:5.41%
controls:4.40%
cases:0.72%
controls:0.73%
—
—
cases:1.99%
controls:0.84%
cases:4.81%
controls:3.94%
cases:14.17%
controls:10.42%
113
835
996
10199
60
486
1049
10548
8
80
1101
10954
—
22
92
1084
10924
52
425
1028
10372
139
1016
842
8735
doxycycline; oral, parenteral
J01AA02 [21602800]
3.4e-01
4.8e-01
6.3e-01
—
7.7e-01
3.2e-01
4.0e-01
cases:22.36%
controls:17.08%
cases:7.84%
controls:5.00%
cases:1.08%
controls:0.58%
—
—
cases:1.45%
controls:0.67%
cases:7.41%
controls:5.49%
cases:23.85%
controls:17.36%
248
1885
861
9149
87
552
1022
10482
12
64
1097
10970
—
16
74
1090
10942
80
593
1000
10204
234
1693
747
8058
hydrocortisone; oral, parenteral
H02AB09 [21602737]
2.7e-01
5.3e-01
—
—
—
1.2e+00
5.3e-01
cases:1.80%
controls:1.39%
cases:0.63%
controls:0.37%
—
—
—
—
—
—
cases:1.11%
controls:0.33%
cases:2.34%
controls:1.39%
20
153
1089
10881
7
41
1102
10993
—
—
—
12
36
1068
10761
23
136
958
9615
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
1.2e+00
—
—
—
—
—
4.1e-01
cases:1.44%
controls:0.44%
—
—
—
—
—
—
—
—
—
—
cases:1.02%
controls:0.68%
16
48
1093
10986
—
—
—
—
—
10
66
971
9685
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
LC2DE [2001306545]
4.0e-01
—
—
—
—
—
1.2e+00
cases:0.81%
controls:0.54%
—
—
—
—
—
—
—
—
—
—
cases:1.43%
controls:0.43%
9
60
1100
10974
—
—
—
—
—
14
42
967
9709
Procedure duration 60 to 89 minutes
ZXE11 [2001311402]
1.2e+00
5.6e-01
—
—
—
3.9e-01
9.4e-01
cases:2.16%
controls:0.67%
cases:0.63%
controls:0.36%
—
—
—
—
—
—
cases:0.46%
controls:0.31%
cases:1.33%
controls:0.52%
24
74
1085
10960
7
40
1102
10994
—
—
—
5
34
1075
10763
13
51
968
9700
Psychiatric monitoring contact
IGY02 [2001304322]
8.0e-01
—
—
—
—
—
1.2e+00
cases:0.54%
controls:0.24%
—
—
—
—
—
—
—
—
—
—
cases:1.63%
controls:0.51%
6
27
1103
11007
—
—
—
—
—
16
50
965
9701
Pain localized to other parts of lower abdomen
R10.3 [45534426]
4.5e-01
5.9e-01
1.4e+00
—
1.2e+00
5.7e-01
7.1e-01
cases:6.31%
controls:4.12%
cases:2.34%
controls:1.31%
cases:0.63%
controls:0.15%
—
—
cases:0.54%
controls:0.16%
cases:2.22%
controls:1.27%
cases:8.66%
controls:4.46%
70
455
1039
10579
26
145
1083
10889
7
17
1102
11017
—
6
18
1100
10998
24
137
1056
10660
85
435
896
9316
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
2.0e-01
3.5e-01
1.1e+00
—
8.7e-01
4.1e-01
2.7e-01
cases:9.20%
controls:7.69%
cases:5.68%
controls:4.09%
cases:1.35%
controls:0.44%
—
—
cases:1.45%
controls:0.61%
cases:6.30%
controls:4.25%
cases:16.00%
controls:12.71%
102
848
1007
10186
63
451
1046
10583
15
48
1094
10986
—
16
67
1090
10949
68
459
1012
10338
157
1239
824
8512
Hip symptom/complaint
L13 [2002000637]
3.0e-01
—
—
—
—
1.1e+00
6.7e-01
cases:1.44%
controls:1.07%
—
—
—
—
—
—
—
—
cases:1.20%
controls:0.39%
cases:2.85%
controls:1.48%
16
118
1093
10916
—
—
—
—
13
42
1067
10755
28
144
953
9607
Extensive abdominal CT
JN3BD [2001305556]
2.0e-01
—
—
—
—
—
1.1e+00
cases:0.54%
controls:0.44%
—
—
—
—
—
—
—
—
—
—
cases:1.33%
controls:0.43%
6
49
1103
10985
—
—
—
—
—
13
42
968
9709
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
6.8e-01
1.1e+00
—
—
—
2.2e-01
2.9e-01
cases:2.34%
controls:1.20%
cases:1.17%
controls:0.38%
—
—
—
—
—
—
cases:0.56%
controls:0.44%
cases:2.14%
controls:1.61%
26
132
1083
10902
13
42
1096
10992
—
—
—
6
48
1074
10749
21
157
960
9594
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
3.3e-01
2.1e-01
2.0e-01
—
4.8e-01
4.4e-01
3.6e-01
cases:14.88%
controls:11.20%
cases:8.39%
controls:6.88%
cases:1.35%
controls:1.11%
—
—
cases:1.90%
controls:1.19%
cases:9.91%
controls:6.63%
cases:21.00%
controls:15.59%
165
1236
944
9798
93
759
1016
10275
15
122
1094
10912
—
21
131
1085
10885
107
716
973
10081
206
1520
775
8231
buprenorphine; parenteral, sublingual, transdermal
N02AE01 [21604287]
3.8e-01
6.0e-01
—
—
—
—
1.1e+00
cases:0.90%
controls:0.62%
cases:0.54%
controls:0.30%
—
—
—
—
—
—
—
—
cases:2.55%
controls:0.84%
10
68
1099
10966
6
33
1103
11001
—
—
—
—
25
82
956
9669
Ileoscopy through colon
UJF30 [2001305028]
1.1e+00
5.4e-01
-1.0e+50
—
—
—
7.3e-01
cases:2.16%
controls:0.72%
cases:0.45%
controls:0.26%
cases:0.00%
controls:0.05%
—
—
—
—
—
—
cases:1.73%
controls:0.84%
24
79
1085
10955
5
29
1104
11005
0
6
1109
11028
—
—
—
17
82
964
9669
Midwife
Z3232 [2001311563]
-4.1e-01
3.2e-01
—
—
—
1.1e+00
4.0e-01
cases:1.53%
controls:2.30%
cases:0.81%
controls:0.59%
—
—
—
—
—
—
cases:1.20%
controls:0.40%
cases:2.45%
controls:1.65%
17
254
1092
10780
9
65
1100
10969
—
—
—
13
43
1067
10754
24
161
957
9590
Acute vaginitis
N76.0 [45543891]
7.8e-01
9.6e-01
—
—
—
3.9e-01
1.1e+00
cases:1.89%
controls:0.88%
cases:0.99%
controls:0.38%
—
—
—
—
—
—
cases:0.46%
controls:0.31%
cases:3.26%
controls:1.10%
21
97
1088
10937
11
42
1098
10992
—
—
—
5
34
1075
10763
32
107
949
9644
Psychologist
Z2445 [2001311558]
1.1e+00
—
—
—
—
-1.0e+50
9.1e-01
cases:1.44%
controls:0.48%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.12%
cases:0.61%
controls:0.25%
16
53
1093
10981
—
—
—
—
0
13
1080
10784
6
24
975
9727
Physiotherapist
Z3226 [2001311560]
3.0e-01
2.4e-01
-1.0e+50
—
—
7.9e-01
1.1e+00
cases:2.34%
controls:1.75%
cases:0.54%
controls:0.43%
cases:0.00%
controls:0.07%
—
—
—
—
cases:0.65%
controls:0.30%
cases:3.26%
controls:1.11%
26
193
1083
10841
6
47
1103
10987
0
8
1109
11026
—
—
7
32
1073
10765
32
108
949
9643
Sytologyspecimen from mouth of uterus
XLD00 [2001306651]
5.1e-01
1.6e-01
—
—
2.3e+00
7.1e-01
1.1e+00
cases:3.16%
controls:1.92%
cases:0.90%
controls:0.77%
—
—
—
—
cases:0.45%
controls:0.05%
cases:1.20%
controls:0.59%
cases:4.79%
controls:1.65%
35
212
1074
10822
10
85
1099
10949
—
—
5
5
1101
11011
13
64
1067
10733
47
161
934
9590
chlorhexidine
S03AA04 [21605193]
-2.4e-02
1.6e-01
—
—
—
1.1e+00
3.8e-01
cases:1.98%
controls:2.03%
cases:0.54%
controls:0.46%
—
—
—
—
—
—
cases:1.20%
controls:0.41%
cases:2.75%
controls:1.90%
22
224
1087
10810
6
51
1103
10983
—
—
—
13
44
1067
10753
27
185
954
9566
other antifungals for topical use - combinations; ointment
D01AE20 [21601959]
-2.4e-02
1.6e-01
—
—
—
1.1e+00
3.8e-01
cases:1.98%
controls:2.03%
cases:0.54%
controls:0.46%
—
—
—
—
—
—
cases:1.20%
controls:0.41%
cases:2.75%
controls:1.90%
22
224
1087
10810
6
51
1103
10983
—
—
—
13
44
1067
10753
27
185
954
9566
Urinary tract infection, site not specified
N39.0 [45548665]
1.9e-01
7.5e-01
—
—
—
1.1e+00
5.5e-01
cases:1.44%
controls:1.20%
cases:1.08%
controls:0.52%
—
—
—
—
—
—
cases:1.20%
controls:0.41%
cases:2.96%
controls:1.72%
16
132
1093
10902
12
57
1097
10977
—
—
—
13
44
1067
10753
29
168
952
9583
triamcinolone and antiseptics
D07BB03 [21602150]
-9.6e-03
1.6e-01
—
—
—
1.1e+00
3.6e-01
cases:2.07%
controls:2.09%
cases:0.54%
controls:0.46%
—
—
—
—
—
—
cases:1.20%
controls:0.41%
cases:2.75%
controls:1.93%
23
231
1086
10803
6
51
1103
10983
—
—
—
13
44
1067
10753
27
188
954
9563
hydrocortisone
D07XA01 [21602180]
-2.8e-02
1.6e-01
—
—
—
1.1e+00
3.8e-01
cases:1.98%
controls:2.04%
cases:0.54%
controls:0.46%
—
—
—
—
—
—
cases:1.20%
controls:0.41%
cases:2.75%
controls:1.90%
22
225
1087
10809
6
51
1103
10983
—
—
—
13
44
1067
10753
27
185
954
9566
chlorhexidine, combinations
D08AC52 [21602208]
-2.4e-02
1.6e-01
—
—
—
1.1e+00
3.8e-01
cases:1.98%
controls:2.03%
cases:0.54%
controls:0.46%
—
—
—
—
—
—
cases:1.20%
controls:0.41%
cases:2.75%
controls:1.90%
22
224
1087
10810
6
51
1103
10983
—
—
—
13
44
1067
10753
27
185
954
9566
hydrocortisone and antiseptics
D07BA04 [21602146]
-2.8e-02
1.6e-01
—
—
—
1.1e+00
3.8e-01
cases:1.98%
controls:2.04%
cases:0.54%
controls:0.46%
—
—
—
—
—
—
cases:1.20%
controls:0.41%
cases:2.75%
controls:1.90%
22
225
1087
10809
6
51
1103
10983
—
—
—
13
44
1067
10753
27
185
954
9566
chlorhexidine
S02AA09 [21605155]
-2.4e-02
1.6e-01
—
—
—
1.1e+00
3.8e-01
cases:1.98%
controls:2.03%
cases:0.54%
controls:0.46%
—
—
—
—
—
—
cases:1.20%
controls:0.41%
cases:2.75%
controls:1.90%
22
224
1087
10810
6
51
1103
10983
—
—
—
13
44
1067
10753
27
185
954
9566
chlorhexidine
D09AA12 [21602275]
-2.4e-02
1.6e-01
—
—
—
1.1e+00
3.8e-01
cases:1.98%
controls:2.03%
cases:0.54%
controls:0.46%
—
—
—
—
—
—
cases:1.20%
controls:0.41%
cases:2.75%
controls:1.90%
22
224
1087
10810
6
51
1103
10983
—
—
—
13
44
1067
10753
27
185
954
9566
Procedure duration 50 to 59 minutes
ZXE06 [2001311400]
1.1e+00
6.9e-01
—
—
-1.0e+50
—
5.4e-01
cases:1.53%
controls:0.53%
cases:0.45%
controls:0.23%
—
—
—
—
cases:0.00%
controls:0.05%
—
—
cases:0.61%
controls:0.36%
17
58
1092
10976
5
25
1104
11009
—
—
0
6
1106
11010
—
6
35
975
9716
Trochanteric bursitis
M70.6 [45606304]
2.7e-01
8.3e-01
—
—
—
—
1.1e+00
cases:0.99%
controls:0.76%
cases:0.54%
controls:0.24%
—
—
—
—
—
—
—
—
cases:3.16%
controls:1.10%
11
84
1098
10950
6
26
1103
11008
—
—
—
—
31
107
950
9644
Vomiting
D10 [2002000309]
7.2e-01
—
—
—
—
—
1.1e+00
cases:2.07%
controls:1.02%
—
—
—
—
—
—
—
—
—
—
cases:2.14%
controls:0.74%
23
113
1086
10921
—
—
—
—
—
21
72
960
9679
Spinal stenosis
M48.0 [45557888]
—
7.7e-01
—
—
-1.0e+50
1.3e+00
1.1e+00
—
—
cases:0.45%
controls:0.21%
—
—
—
—
cases:0.00%
controls:0.05%
cases:0.65%
controls:0.18%
cases:1.63%
controls:0.56%
—
5
23
1104
11011
—
—
0
6
1106
11010
7
19
1073
10778
16
55
965
9696
clindamycin
D10AF01 [21602305]
5.7e-01
2.4e-01
—
—
—
—
1.1e+00
cases:2.07%
controls:1.19%
cases:0.54%
controls:0.43%
—
—
—
—
—
—
—
—
cases:3.16%
controls:1.11%
23
131
1086
10903
6
47
1103
10987
—
—
—
—
31
108
950
9643
Essential (primary) hypertension
I10 [45591453]
-1.5e-02
1.7e-01
1.1e+00
—
6.7e-01
1.2e-01
8.2e-02
cases:4.69%
controls:4.76%
cases:2.98%
controls:2.53%
cases:1.17%
controls:0.41%
—
—
cases:0.90%
controls:0.46%
cases:3.06%
controls:2.73%
cases:8.46%
controls:7.85%
52
525
1057
10509
33
279
1076
10755
13
45
1096
10989
—
10
51
1096
10965
33
295
1047
10502
83
765
898
8986
Dysthymia
F34.1 [45586238]
1.1e+00
—
—
—
—
1.1e+00
7.3e-01
cases:1.35%
controls:0.47%
—
—
—
—
—
—
—
—
cases:0.56%
controls:0.19%
cases:1.02%
controls:0.49%
15
52
1094
10982
—
—
—
—
6
21
1074
10776
10
48
971
9703
Fasting glucose [Moles/volume] in Serum or Plasma
14771-0 [3018251]
1.8e-01
8.6e-02
2.9e-01
—
1.1e+00
1.6e-01
1.5e-01
cases:18.94%
controls:16.26%
cases:9.11%
controls:8.42%
cases:1.44%
controls:1.08%
—
—
cases:2.35%
controls:0.84%
cases:10.37%
controls:8.94%
cases:27.52%
controls:24.57%
210
1794
899
9240
101
929
1008
10105
16
119
1093
10915
—
26
92
1080
10924
112
965
968
9832
270
2396
711
7355
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
1.0e+00
5.1e-01
-1.0e+50
—
—
6.1e-01
2.6e-01
cases:2.34%
controls:0.83%
cases:0.63%
controls:0.38%
cases:0.00%
controls:0.10%
—
—
—
—
cases:0.83%
controls:0.45%
cases:1.43%
controls:1.11%
26
92
1083
10942
7
42
1102
10992
0
11
1109
11023
—
—
9
49
1071
10748
14
108
967
9643
Hospital outpatient
ZY010 [2001311599]
1.0e+00
7.3e-01
9.1e-01
—
—
4.6e-01
7.9e-01
cases:2.34%
controls:0.84%
cases:0.90%
controls:0.44%
cases:0.45%
controls:0.18%
—
—
—
—
cases:0.56%
controls:0.35%
cases:1.12%
controls:0.51%
26
93
1083
10941
10
48
1099
10986
5
20
1104
11014
—
—
6
38
1074
10759
11
50
970
9701
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
1.4e-01
2.3e-01
—
—
3.8e-01
5.6e-01
4.7e-01
cases:8.66%
controls:7.63%
cases:4.15%
controls:3.33%
—
—
—
—
cases:0.54%
controls:0.37%
cases:4.35%
controls:2.53%
cases:12.84%
controls:8.42%
96
842
1013
10192
46
367
1063
10667
—
—
6
41
1100
10975
47
273
1033
10524
126
821
855
8930
Respiratory and circulatory monitoring
WX700 [2001310817]
5.1e-01
4.6e-01
—
—
—
—
1.0e+00
cases:1.89%
controls:1.15%
cases:0.63%
controls:0.40%
—
—
—
—
—
—
—
—
cases:2.55%
controls:0.92%
21
127
1088
10907
7
44
1102
10990
—
—
—
—
25
90
956
9661
Kolposcopy
ULA02 [2001306679]
3.4e-01
9.5e-01
—
—
—
1.0e+00
1.0e+00
cases:2.07%
controls:1.49%
cases:1.35%
controls:0.53%
—
—
—
—
—
—
cases:1.11%
controls:0.41%
cases:3.77%
controls:1.38%
23
164
1086
10870
15
58
1094
10976
—
—
—
12
44
1068
10753
37
135
944
9616
Outcome of delivery
Z37 [45581024]
-3.3e-01
-7.5e-02
1.3e+00
—
—
-9.1e-02
1.6e-01
cases:11.90%
controls:15.83%
cases:4.06%
controls:4.36%
cases:1.17%
controls:0.31%
—
—
—
—
cases:3.98%
controls:4.34%
cases:14.78%
controls:12.89%
132
1747
977
9287
45
481
1064
10553
13
34
1096
11000
—
—
43
469
1037
10328
145
1257
836
8494
Root filling of tooth with onetwo root canals
SGB20 [2001310389]
1.0e+00
—
-1.0e+50
—
—
1.2e+00
7.6e-02
cases:1.53%
controls:0.56%
—
—
cases:0.00%
controls:0.05%
—
—
—
—
cases:0.46%
controls:0.14%
cases:0.92%
controls:0.85%
17
62
1092
10972
—
0
5
1109
11029
—
—
5
15
1075
10782
9
83
972
9668
fusidic acid; ointment
D06AX01 [21602062]
4.3e-01
1.0e+00
-1.0e+50
—
—
1.3e-01
3.1e-01
cases:4.15%
controls:2.74%
cases:2.16%
controls:0.80%
cases:0.00%
controls:0.08%
—
—
—
—
cases:0.93%
controls:0.82%
cases:4.69%
controls:3.47%
46
302
1063
10732
24
88
1085
10946
0
9
1109
11025
—
—
10
88
1070
10709
46
338
935
9413
fusidic acid
D09AA02 [21602265]
4.3e-01
1.0e+00
-1.0e+50
—
—
1.3e-01
3.1e-01
cases:4.15%
controls:2.74%
cases:2.16%
controls:0.80%
cases:0.00%
controls:0.08%
—
—
—
—
cases:0.93%
controls:0.82%
cases:4.69%
controls:3.47%
46
302
1063
10732
24
88
1085
10946
0
9
1109
11025
—
—
10
88
1070
10709
46
338
935
9413
Spinalanesthesia
WX320 [2001310799]
1.4e-01
4.8e-01
—
—
—
1.0e+00
5.4e-01
cases:2.52%
controls:2.19%
cases:1.26%
controls:0.79%
—
—
—
—
—
—
cases:1.94%
controls:0.72%
cases:3.77%
controls:2.23%
28
242
1081
10792
14
87
1095
10947
—
—
—
21
78
1059
10719
37
217
944
9534
Sedation and analgesia
WX002 [2001310758]
-4.2e-01
3.2e-01
—
—
—
5.4e-01
9.9e-01
cases:1.08%
controls:1.64%
cases:0.45%
controls:0.33%
—
—
—
—
—
—
cases:0.56%
controls:0.32%
cases:2.96%
controls:1.12%
12
181
1097
10853
5
36
1104
10998
—
—
—
6
35
1074
10762
29
109
952
9642
Differential panel, method unspecified - Blood
69738-3 [42870588]
4.9e-01
2.6e-01
-1.9e-01
—
9.0e-01
2.0e-01
4.9e-01
cases:7.30%
controls:4.60%
cases:3.52%
controls:2.74%
cases:0.45%
controls:0.54%
—
—
cases:1.36%
controls:0.55%
cases:3.06%
controls:2.51%
cases:9.58%
controls:6.08%
81
508
1028
10526
39
302
1070
10732
5
60
1104
10974
—
15
61
1091
10955
33
271
1047
10526
94
593
887
9158
oxazepam; oral
N05BA04 [21604569]
4.3e-01
2.5e-01
6.2e-01
—
4.4e-01
5.5e-01
3.2e-01
cases:6.76%
controls:4.51%
cases:3.16%
controls:2.47%
cases:0.90%
controls:0.49%
—
—
cases:0.81%
controls:0.53%
cases:4.26%
controls:2.49%
cases:7.44%
controls:5.53%
75
498
1034
10536
35
273
1074
10761
10
54
1099
10980
—
9
58
1097
10958
46
269
1034
10528
73
539
908
9212
Pain in thoracic spine
M54.6 [45606247]
9.8e-01
—
-1.0e+50
—
—
—
4.4e-01
cases:1.62%
controls:0.62%
—
—
cases:0.00%
controls:0.05%
—
—
—
—
—
—
cases:1.43%
controls:0.92%
18
68
1091
10966
—
0
6
1109
11028
—
—
—
14
90
967
9661
ECG with 12 standard connections
XF400 [2001303368]
4.5e-01
—
—
—
—
—
9.6e-01
cases:1.35%
controls:0.87%
—
—
—
—
—
—
—
—
—
—
cases:1.94%
controls:0.75%
15
96
1094
10938
—
—
—
—
—
19
73
962
9678
Excessive and frequent menstruation with irregular cycle
N92.1 [45539073]
4.4e-01
3.2e-01
—
—
-1.0e+50
—
9.6e-01
cases:1.35%
controls:0.88%
cases:0.45%
controls:0.33%
—
—
—
—
cases:0.00%
controls:0.05%
—
—
cases:2.34%
controls:0.91%
15
97
1094
10937
5
36
1104
10998
—
—
0
6
1106
11010
—
23
89
958
9662
valproic acid; oral, parenteral, rectal
N03AG01 [21604422]
9.5e-01
7.5e-01
—
—
1.2e+00
5.8e-01
4.2e-01
cases:1.80%
controls:0.71%
cases:0.90%
controls:0.43%
—
—
—
—
cases:0.45%
controls:0.14%
cases:0.74%
controls:0.42%
cases:1.12%
controls:0.74%
20
78
1089
10956
10
47
1099
10987
—
—
5
15
1101
11001
8
45
1072
10752
11
72
970
9679
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
9.5e-01
4.5e-01
—
—
—
7.3e-01
2.2e-02
cases:2.16%
controls:0.85%
cases:0.54%
controls:0.34%
—
—
—
—
—
—
cases:0.56%
controls:0.27%
cases:1.12%
controls:1.10%
24
94
1085
10940
6
38
1103
10996
—
—
—
6
29
1074
10768
11
107
970
9644
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
3.7e-01
3.1e-01
6.3e-01
—
6.9e-01
5.0e-01
4.4e-01
cases:7.39%
controls:5.22%
cases:3.97%
controls:2.95%
cases:0.54%
controls:0.29%
—
—
cases:0.72%
controls:0.36%
cases:5.09%
controls:3.14%
cases:13.97%
controls:9.46%
82
576
1027
10458
44
325
1065
10709
6
32
1103
11002
—
8
40
1098
10976
55
339
1025
10458
137
922
844
8829
Biopsy of endometrium
LCA06 [2001306551]
5.4e-01
1.1e+00
—
—
—
3.1e-01
9.4e-01
cases:2.25%
controls:1.33%
cases:1.08%
controls:0.37%
—
—
—
—
—
—
cases:0.56%
controls:0.41%
cases:3.26%
controls:1.30%
25
147
1084
10887
12
41
1097
10993
—
—
—
6
44
1074
10753
32
127
949
9624
pantoprazole; oral, parenteral
A02BC02 [21600097]
3.3e-01
3.2e-01
1.7e-01
—
6.0e-01
3.1e-01
6.1e-01
cases:14.61%
controls:10.96%
cases:7.30%
controls:5.41%
cases:1.08%
controls:0.92%
—
—
cases:1.54%
controls:0.85%
cases:6.94%
controls:5.21%
cases:20.69%
controls:12.45%
162
1209
947
9825
81
597
1028
10437
12
101
1097
10933
—
17
94
1089
10922
75
562
1005
10235
203
1214
778
8537
Obesity
E66 [45547648]
7.6e-01
6.5e-01
—
—
—
—
9.4e-01
cases:0.81%
controls:0.38%
cases:0.45%
controls:0.24%
—
—
—
—
—
—
—
—
cases:1.83%
controls:0.73%
9
42
1100
10992
5
26
1104
11008
—
—
—
—
18
71
963
9680
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
4.3e-01
3.0e-01
5.1e-01
—
7.8e-01
4.9e-01
5.0e-01
cases:8.39%
controls:5.62%
cases:3.88%
controls:2.89%
cases:0.72%
controls:0.44%
—
—
cases:1.08%
controls:0.50%
cases:4.35%
controls:2.71%
cases:13.35%
controls:8.52%
93
620
1016
10414
43
319
1066
10715
8
48
1101
10986
—
12
55
1094
10961
47
293
1033
10504
131
831
850
8920
Blasts/Leukocytes in Blood
26446-5 [3025159]
9.2e-01
4.8e-01
—
—
—
6.4e-01
5.8e-01
cases:1.62%
controls:0.65%
cases:0.90%
controls:0.56%
—
—
—
—
—
—
cases:0.93%
controls:0.49%
cases:2.45%
controls:1.38%
18
72
1091
10962
10
62
1099
10972
—
—
—
10
53
1070
10744
24
135
957
9616
Recurrent depression, moderate episode without somatic syndrome
F33.10 [2000501984]
9.2e-01
6.0e-01
—
—
—
-1.1e-01
1.6e-01
cases:2.34%
controls:0.95%
cases:0.90%
controls:0.50%
—
—
—
—
—
—
cases:0.56%
controls:0.62%
cases:1.43%
controls:1.22%
26
105
1083
10929
10
55
1099
10979
—
—
—
6
67
1074
10730
14
119
967
9632
Abdominal pain localized other
D06 [2002000305]
4.8e-01
—
—
—
—
6.0e-01
9.1e-01
cases:1.53%
controls:0.95%
—
—
—
—
—
—
—
—
cases:0.56%
controls:0.31%
cases:2.75%
controls:1.13%
17
105
1092
10929
—
—
—
—
6
33
1074
10764
27
110
954
9641
Pain, unspecified
R52.9 [45544151]
7.2e-01
—
—
—
—
—
8.9e-01
cases:1.26%
controls:0.62%
—
—
—
—
—
—
—
—
—
—
cases:2.14%
controls:0.89%
14
68
1095
10966
—
—
—
—
—
21
87
960
9664
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
5.4e-01
8.1e-01
—
—
—
6.2e-01
8.9e-01
cases:1.08%
controls:0.63%
cases:0.81%
controls:0.36%
—
—
—
—
—
—
cases:0.46%
controls:0.25%
cases:2.14%
controls:0.89%
12
70
1097
10964
9
40
1100
10994
—
—
—
5
27
1075
10770
21
87
960
9664
Choriogonadotropin [Presence] in Serum or Plasma
2118-8 [3003191]
-7.9e-02
2.7e-01
—
—
—
2.2e-01
8.7e-01
cases:1.44%
controls:1.56%
cases:0.72%
controls:0.55%
—
—
—
—
—
—
cases:0.65%
controls:0.52%
cases:3.47%
controls:1.48%
16
172
1093
10862
8
61
1101
10973
—
—
—
7
56
1073
10741
34
144
947
9607
lamotrigine; oral
N03AX09 [21604431]
8.7e-01
5.3e-01
—
—
—
5.5e-01
8.0e-01
cases:2.16%
controls:0.92%
cases:0.81%
controls:0.48%
—
—
—
—
—
—
cases:0.83%
controls:0.48%
cases:2.14%
controls:0.97%
24
101
1085
10933
9
53
1100
10981
—
—
—
9
52
1071
10745
21
95
960
9656
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
8.7e-01
6.6e-01
—
—
—
6.6e-01
6.0e-01
cases:1.71%
controls:0.73%
cases:1.08%
controls:0.56%
—
—
—
—
—
—
cases:0.93%
controls:0.48%
cases:2.45%
controls:1.36%
19
80
1090
10954
12
62
1097
10972
—
—
—
10
52
1070
10745
24
133
957
9618
Cystitis
N30 [45563012]
2.1e-01
1.2e-01
—
—
—
5.6e-01
8.7e-01
cases:0.99%
controls:0.81%
cases:0.45%
controls:0.40%
—
—
—
—
—
—
cases:0.65%
controls:0.37%
cases:3.26%
controls:1.39%
11
89
1098
10945
5
44
1104
10990
—
—
—
7
40
1073
10757
32
136
949
9615
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
3.4e-01
2.5e-01
—
—
—
8.5e-01
3.8e-01
cases:4.42%
controls:3.17%
cases:1.98%
controls:1.56%
—
—
—
—
—
—
cases:3.24%
controls:1.41%
cases:7.34%
controls:5.14%
49
350
1060
10684
22
172
1087
10862
—
—
—
35
152
1045
10645
72
501
909
9250
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
3.2e-01
6.4e-01
9.1e-01
—
1.7e+00
6.7e-01
8.5e-01
cases:3.34%
controls:2.46%
cases:1.71%
controls:0.91%
cases:0.45%
controls:0.18%
—
—
cases:0.45%
controls:0.08%
cases:1.85%
controls:0.95%
cases:5.61%
controls:2.47%
37
271
1072
10763
19
100
1090
10934
5
20
1104
11014
—
5
9
1101
11007
20
103
1060
10694
55
241
926
9510
itraconazole; oral, parenteral
J02AC02 [21603081]
5.1e-01
5.1e-01
—
—
—
5.4e-01
8.4e-01
cases:2.71%
controls:1.64%
cases:0.72%
controls:0.44%
—
—
—
—
—
—
cases:0.56%
controls:0.32%
cases:3.16%
controls:1.38%
30
181
1079
10853
8
48
1101
10986
—
—
—
6
35
1074
10762
31
135
950
9616
nitrofurantoin; oral
J01XE01 [21603058]
7.5e-02
4.7e-01
—
—
-1.0e+50
8.4e-01
3.9e-01
cases:3.25%
controls:3.02%
cases:1.71%
controls:1.08%
—
—
—
—
cases:0.00%
controls:0.16%
cases:2.22%
controls:0.97%
cases:4.99%
controls:3.43%
36
333
1073
10701
19
119
1090
10915
—
—
0
18
1106
10998
24
105
1056
10692
49
334
932
9417
Microorganisms panel - Urine sediment
58435-9 [40761536]
4.5e-01
6.2e-01
—
1.0e+50
—
5.7e-02
8.4e-01
cases:2.43%
controls:1.57%
cases:1.17%
controls:0.63%
—
—
cases:0.54%
controls:0.00%
—
—
cases:0.83%
controls:0.79%
cases:2.96%
controls:1.30%
27
173
1082
10861
13
70
1096
10964
—
6
0
1103
11034
—
9
85
1071
10712
29
127
952
9624
Bacteria [Presence] in Urine
87829-8 [36304419]
1.4e-01
2.5e-01
—
—
1.4e+00
6.7e-01
8.3e-01
cases:3.61%
controls:3.16%
cases:1.71%
controls:1.34%
—
—
—
—
cases:0.54%
controls:0.14%
cases:2.59%
controls:1.34%
cases:8.26%
controls:3.77%
40
349
1069
10685
19
148
1090
10886
—
—
6
15
1100
11001
28
145
1052
10652
81
368
900
9383
Treatment plan or consultation
WZC00 [2001310885]
1.8e-01
2.0e-01
—
—
1.5e+00
8.3e-01
2.7e-01
cases:5.50%
controls:4.64%
cases:1.71%
controls:1.41%
—
—
—
—
cases:0.63%
controls:0.15%
cases:3.24%
controls:1.44%
cases:6.73%
controls:5.23%
61
512
1048
10522
19
156
1090
10878
—
—
7
16
1099
11000
35
156
1045
10641
66
510
915
9241
Upper respiratory infection acute
R74 [2002000942]
4.2e-01
2.7e-01
5.7e-01
—
-1.0e+50
1.7e-01
4.0e-01
cases:10.64%
controls:7.23%
cases:3.43%
controls:2.65%
cases:0.54%
controls:0.31%
—
—
cases:0.00%
controls:0.44%
cases:3.06%
controls:2.60%
cases:12.03%
controls:8.40%
118
798
991
10236
38
292
1071
10742
6
34
1103
11000
—
0
49
1106
10967
33
281
1047
10516
118
819
863
8932
Pathology report gross observation
24419-4 [3002256]
5.5e-01
-8.2e-02
—
—
—
7.5e-01
8.2e-01
cases:2.25%
controls:1.31%
cases:0.45%
controls:0.49%
—
—
—
—
—
—
cases:0.74%
controls:0.35%
cases:3.16%
controls:1.42%
25
145
1084
10889
5
54
1104
10980
—
—
—
8
38
1072
10759
31
138
950
9613
Diabetes non-insulin dependent
T90 [2002001131]
3.2e-01
5.8e-01
—
—
1.3e+00
8.2e-01
3.9e-01
cases:1.98%
controls:1.45%
cases:1.53%
controls:0.86%
—
—
—
—
cases:0.54%
controls:0.15%
cases:2.04%
controls:0.91%
cases:3.16%
controls:2.15%
22
160
1087
10874
17
95
1092
10939
—
—
6
17
1100
10999
22
98
1058
10699
31
210
950
9541
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
2.8e-01
3.5e-01
—
—
—
8.1e-01
8.2e-01
cases:1.80%
controls:1.37%
cases:0.90%
controls:0.63%
—
—
—
—
—
—
cases:1.30%
controls:0.58%
cases:4.99%
controls:2.27%
20
151
1089
10883
10
70
1099
10964
—
—
—
14
63
1066
10734
49
221
932
9530
Chest pain, unspecified
R07.4 [45558450]
8.1e-01
2.7e-01
—
—
—
-1.3e-01
4.0e-01
cases:3.61%
controls:1.64%
cases:0.72%
controls:0.55%
—
—
—
—
—
—
cases:0.46%
controls:0.53%
cases:3.57%
controls:2.43%
40
181
1069
10853
8
61
1101
10973
—
—
—
5
57
1075
10740
35
237
946
9514
diclofenac; oral, parenteral, rectal
M01AB05 [21603945]
3.8e-01
3.2e-02
4.6e-01
—
1.2e-01
3.8e-01
4.3e-01
cases:17.76%
controls:12.88%
cases:4.33%
controls:4.20%
cases:1.08%
controls:0.69%
—
—
cases:0.63%
controls:0.56%
cases:6.11%
controls:4.26%
cases:20.29%
controls:14.23%
197
1421
912
9613
48
463
1061
10571
12
76
1097
10958
—
7
62
1099
10954
66
460
1014
10337
199
1388
782
8363
tizanidine; oral
M03BX02 [21604116]
3.7e-01
3.2e-01
2.2e-01
—
2.9e-01
4.3e-01
4.4e-01
cases:17.31%
controls:12.69%
cases:6.22%
controls:4.60%
cases:0.81%
controls:0.65%
—
—
cases:0.63%
controls:0.47%
cases:6.76%
controls:4.52%
cases:21.00%
controls:14.61%
192
1400
917
9634
69
508
1040
10526
9
72
1100
10962
—
7
52
1099
10964
73
488
1007
10309
206
1425
775
8326
Severe depressive episode without psychotic symptoms
F32.2 [45557202]
8.0e-01
—
—
—
—
2.9e-01
2.7e-01
cases:2.07%
controls:0.94%
—
—
—
—
—
—
—
—
cases:0.56%
controls:0.42%
cases:1.43%
controls:1.10%
23
104
1086
10930
—
—
—
—
6
45
1074
10752
14
107
967
9644
Plastic And Reconstructive Surgery
24 [38004467]
4.3e-02
6.8e-01
—
—
1.7e+00
6.5e-01
8.0e-01
cases:2.16%
controls:2.08%
cases:1.53%
controls:0.78%
—
—
—
—
cases:0.54%
controls:0.10%
cases:1.57%
controls:0.82%
cases:5.20%
controls:2.41%
24
229
1085
10805
17
86
1092
10948
—
—
6
11
1100
11005
17
89
1063
10708
51
235
930
9516
Observation for other suspected diseases and conditions
Z03.89 [2000503757]
6.8e-01
7.6e-01
—
—
—
1.7e-01
8.0e-01
cases:1.80%
controls:0.92%
cases:0.54%
controls:0.25%
—
—
—
—
—
—
cases:0.46%
controls:0.39%
cases:2.75%
controls:1.26%
20
102
1089
10932
6
28
1103
11006
—
—
—
5
42
1075
10755
27
123
954
9628
The fear of childbirth
O99.80 [2000503219]
-1.2e-01
3.5e-01
—
—
-1.0e+50
—
7.9e-01
cases:0.99%
controls:1.11%
cases:0.63%
controls:0.44%
—
—
—
—
cases:0.00%
controls:0.06%
—
—
cases:2.34%
controls:1.08%
11
123
1098
10911
7
49
1102
10985
—
—
0
7
1106
11009
—
23
105
958
9646
Dorsalgia, unspecified
M54.9 [45538791]
-1.0e-01
7.5e-01
-1.0e+50
—
—
1.2e+00
7.9e-01
cases:0.90%
controls:1.00%
cases:0.63%
controls:0.30%
cases:0.00%
controls:0.05%
—
—
—
—
cases:1.02%
controls:0.31%
cases:2.75%
controls:1.27%
10
110
1099
10924
7
33
1102
11001
0
6
1109
11028
—
—
11
34
1069
10763
27
124
954
9627
Thorax X-ray examination
GD1AA [2001303617]
4.5e-01
5.7e-01
—
—
—
7.3e-01
7.9e-01
cases:5.50%
controls:3.59%
cases:2.07%
controls:1.18%
—
—
—
—
—
—
cases:2.13%
controls:1.04%
cases:7.95%
controls:3.78%
61
396
1048
10638
23
130
1086
10904
—
—
—
23
112
1057
10685
78
369
903
9382
Spirometry for bronchospasm with prolonged evaluation after bronchodilator
113016006 [4010399]
2.4e-01
—
—
—
—
—
7.8e-01
cases:1.08%
controls:0.85%
—
—
—
—
—
—
—
—
—
—
cases:2.55%
controls:1.18%
12
94
1097
10940
—
—
—
—
—
25
115
956
9636
Pulpitis
K04.0 [45591570]
7.8e-01
1.0e+00
—
—
-1.0e+50
3.4e-01
3.2e-01
cases:2.71%
controls:1.26%
cases:0.72%
controls:0.25%
—
—
—
—
cases:0.00%
controls:0.08%
cases:0.65%
controls:0.46%
cases:1.83%
controls:1.33%
30
139
1079
10895
8
28
1101
11006
—
—
0
9
1106
11007
7
50
1073
10747
18
130
963
9621
Physiotherapy
R4110 [2001310233]
1.8e-01
1.7e-01
—
—
—
8.6e-02
7.7e-01
cases:2.98%
controls:2.50%
cases:1.17%
controls:0.99%
—
—
—
—
—
—
cases:1.02%
controls:0.94%
cases:5.50%
controls:2.62%
33
276
1076
10758
13
109
1096
10925
—
—
—
11
101
1069
10696
54
255
927
9496
long-acting sulfonamides - combinations
J01ED20 [21602959]
2.2e-01
9.4e-01
—
—
—
7.0e-01
7.7e-01
cases:2.25%
controls:1.81%
cases:0.90%
controls:0.35%
—
—
—
—
—
—
cases:0.74%
controls:0.37%
cases:2.75%
controls:1.29%
25
200
1084
10834
10
39
1099
10995
—
—
—
8
40
1072
10757
27
126
954
9625
cough suppressants and mucolytics
R05FB01 [21603441]
2.2e-01
9.4e-01
—
—
—
7.0e-01
7.7e-01
cases:2.25%
controls:1.81%
cases:0.90%
controls:0.35%
—
—
—
—
—
—
cases:0.74%
controls:0.37%
cases:2.75%
controls:1.29%
25
200
1084
10834
10
39
1099
10995
—
—
—
8
40
1072
10757
27
126
954
9625
cough suppressants and expectorants
R05FB02 [21603442]
2.2e-01
9.4e-01
—
—
—
7.0e-01
7.7e-01
cases:2.25%
controls:1.81%
cases:0.90%
controls:0.35%
—
—
—
—
—
—
cases:0.74%
controls:0.37%
cases:2.75%
controls:1.29%
25
200
1084
10834
10
39
1099
10995
—
—
—
8
40
1072
10757
27
126
954
9625
hydroxyethylpromethazine, combinations
R06AD55 [21603490]
2.2e-01
9.4e-01
—
—
—
7.0e-01
7.7e-01
cases:2.25%
controls:1.81%
cases:0.90%
controls:0.35%
—
—
—
—
—
—
cases:0.74%
controls:0.37%
cases:2.75%
controls:1.29%
25
200
1084
10834
10
39
1099
10995
—
—
—
8
40
1072
10757
27
126
954
9625
intermediate-acting sulfonamides - combinations
J01EC20 [21602948]
2.2e-01
9.4e-01
—
—
—
7.0e-01
7.7e-01
cases:2.25%
controls:1.81%
cases:0.90%
controls:0.35%
—
—
—
—
—
—
cases:0.74%
controls:0.37%
cases:2.75%
controls:1.29%
25
200
1084
10834
10
39
1099
10995
—
—
—
8
40
1072
10757
27
126
954
9625
diphenhydramine, combinations
R06AA52 [21603454]
2.2e-01
9.4e-01
—
—
—
7.0e-01
7.7e-01
cases:2.25%
controls:1.81%
cases:0.90%
controls:0.35%
—
—
—
—
—
—
cases:0.74%
controls:0.37%
cases:2.75%
controls:1.29%
25
200
1084
10834
10
39
1099
10995
—
—
—
8
40
1072
10757
27
126
954
9625
promethazine, combinations
R06AD52 [21603489]
2.2e-01
9.4e-01
—
—
—
7.0e-01
7.7e-01
cases:2.25%
controls:1.81%
cases:0.90%
controls:0.35%
—
—
—
—
—
—
cases:0.74%
controls:0.37%
cases:2.75%
controls:1.29%
25
200
1084
10834
10
39
1099
10995
—
—
—
8
40
1072
10757
27
126
954
9625
short-acting sulfonamides - combinations
J01EB20 [21602943]
2.2e-01
9.4e-01
—
—
—
7.0e-01
7.7e-01
cases:2.25%
controls:1.81%
cases:0.90%
controls:0.35%
—
—
—
—
—
—
cases:0.74%
controls:0.37%
cases:2.75%
controls:1.29%
25
200
1084
10834
10
39
1099
10995
—
—
—
8
40
1072
10757
27
126
954
9625
dextromethorphan, combinations; oral
N07XX59 [43534835]
2.2e-01
9.4e-01
—
—
—
7.0e-01
7.7e-01
cases:2.25%
controls:1.81%
cases:0.90%
controls:0.35%
—
—
—
—
—
—
cases:0.74%
controls:0.37%
cases:2.75%
controls:1.29%
25
200
1084
10834
10
39
1099
10995
—
—
—
8
40
1072
10757
27
126
954
9625
Lumbago with sciatica
M54.4 [45553205]
3.6e-01
3.1e-01
—
—
—
5.5e-01
7.7e-01
cases:1.89%
controls:1.33%
cases:0.81%
controls:0.60%
—
—
—
—
—
—
cases:0.83%
controls:0.48%
cases:4.38%
controls:2.08%
21
147
1088
10887
9
66
1100
10968
—
—
—
9
52
1071
10745
43
203
938
9548
Medical abortion, complete or unspecified, without complication
O04.9 [45543909]
7.7e-01
9.2e-01
—
—
—
8.3e-01
6.0e-01
cases:3.34%
controls:1.58%
cases:0.99%
controls:0.40%
—
—
—
—
—
—
cases:0.93%
controls:0.41%
cases:2.24%
controls:1.24%
37
174
1072
10860
11
44
1098
10990
—
—
—
10
44
1070
10753
22
121
959
9630
alprazolam; oral
N05BA12 [21604577]
7.6e-01
-3.8e-02
-1.0e+50
—
-1.0e+50
3.1e-01
4.2e-01
cases:2.34%
controls:1.11%
cases:0.54%
controls:0.56%
cases:0.00%
controls:0.15%
—
—
cases:0.00%
controls:0.19%
cases:0.74%
controls:0.55%
cases:1.94%
controls:1.28%
26
123
1083
10911
6
62
1103
10972
0
16
1109
11018
—
0
21
1106
10995
8
59
1072
10738
19
125
962
9626
Osmolality of Urine
2695-5 [3026782]
3.7e-01
4.8e-01
—
—
1.6e+00
6.0e-01
7.6e-01
cases:3.70%
controls:2.57%
cases:1.44%
controls:0.90%
—
—
—
—
cases:0.45%
controls:0.09%
cases:1.57%
controls:0.87%
cases:5.20%
controls:2.51%
41
284
1068
10750
16
99
1093
10935
—
—
5
10
1101
11006
17
94
1063
10703
51
245
930
9506

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
311
1182
3.24
62.34
1.8
1.9
—
—
—
0
0
223
1080
2.32
25.48
1.7
1.6
—
—
—
0
0
449
3170
1.69
15.59
6.9
6.2
—
—
—
0
0
818
6900
1.66
12.84
5.2
4.1
6895.67
2651.64
e6/l
—
9
77
609
4813
1.57
12.37
5.3
5.7
9.51
9.94
umol/l
0.45
579
4579
463
3437
1.58
12.36
9.9
8.9
1.12
1.10
inr
0.32
394
2845
293
1953
1.67
12.07
3.8
3.8
—
—
—
0
0
599
4743
1.55
11.86
7.2
6.2
2.86
2.74
%
0.70
566
4482
599
4751
1.55
11.72
7.3
6.3
7.98
8.24
%
1.84
567
4498
596
4737
1.54
11.44
7.4
6.2
0.74
0.69
%
1.14
562
4464
622
4997
1.54
11.32
2.9
2.6
—
—
estimate
—
0
0
663
5415
1.54
11.08
7.0
6.4
0.19
0.18
e9/l
1.26
596
4851
849
7334
1.62
11.03
8.2
7.3
73.21
74.45
u/l
0.32
802
6968
641
5226
1.52
10.58
7.0
6.2
0.04
0.04
e9/l
2.02
564
4616
397
2924
1.55
10.56
2.7
2.3
64.61
59.33
u/l
0.19
370
2701
502
3893
1.52
10.49
5.7
4.3
36.30
36.72
g/l
1.00
477
3677
638
5221
1.50
10.17
7.0
6.2
0.54
0.53
e9/l
1.03
560
4619
393
2944
1.51
9.43
3.1
2.9
22.30
54.41
ng/l
0.63
193
1532
604
4940
1.47
9.31
7.2
6.1
29.31
29.49
%
0.18
575
4713
647
5376
1.47
9.11
7.0
6.1
1.99
1.97
e9/l
0.14
585
4851
594
4858
1.46
9.06
7.0
6.0
57.00
56.55
%
0.46
568
4676
693
5847
1.47
8.94
8.6
9.1
4.16
3.94
e9/l
1.93
609
5181
495
3938
1.45
8.56
2.1
1.9
105.98
98.56
pmol/l
1.11
258
2084
427
3309
1.46
8.44
2.6
2.0
—
—
—
0
0
599
4947
1.44
8.43
2.9
2.4
73.99
75.98
nmol/l
1.00
557
4624
242
1665
1.58
8.42
3.1
2.5
106.23
95.52
ug/g
0.31
189
1307
202
1356
1.60
7.76
3.1
3.0
0.82
0.82
mmol/l
0.24
190
1286
1075
10127
2.06
7.74
16.5
12.0
19.98
19.30
mg/l
0.30
910
8132
531
4362
1.41
7.31
7.1
5.8
1.22
1.22
mmol/l
0.56
455
3760
184
1225
1.60
7.30
1.7
1.7
999.21
1199.86
nmol/l
2.86
151
944
322
2444
1.44
6.81
1.8
1.7
1.00
0.89
mg/l
0.38
241
1845
98
562
1.81
6.74
1.4
1.3
—
—
—
0
0
100
585
1.78
6.44
9.3
6.6
—
—
—
0
0
207
1456
1.52
6.39
3.1
2.3
13.43
14.07
umol/l
0.71
199
1353
627
5369
1.37
6.38
5.0
4.1
6.50
6.28
mmol/l
1.48
595
4928
395
3139
1.40
6.37
3.6
2.5
—
—
—
0
0
329
2540
1.41
6.25
2.2
2.1
97.27
128.70
u/l
5.44
314
2431
249
1828
1.46
6.21
1.6
1.6
30556028.05
34868025.47
pmol/l
0.05
216
1586
525
4383
1.37
6.20
2.1
2.0
—
—
—
0
0
189
1314
1.53
6.15
3.0
2.2
2.50
2.45
g/l
0.55
177
1222
340
2649
1.40
6.11
2.9
2.1
2.70
2.66
mg/l
0.13
304
2301
161
1082
1.57
6.10
1.9
2.2
382.48
380.69
nmol/l
0.04
146
1012
415
3344
1.38
6.09
2.7
3.3
2.35
2.35
mmol/l
0.10
369
3113
257
1905
1.45
6.08
2.7
2.5
10.29
9.12
e6/l
0.37
239
1723
224
1621
1.48
6.00
3.0
2.7
516.56
504.72
mosm/kgh2o
0.35
203
1423
318
2468
1.40
5.80
1.7
1.6
19.05
21.19
nmol/l
2.08
277
2159
172
1187
1.53
5.78
3.2
2.3
21.87
23.12
%
0.64
160
1103
360
2861
1.38
5.67
3.5
2.9
44.81
56.45
e6/l
0.19
284
2081
468
3886
1.35
5.53
6.6
5.1
1.22
1.22
mmol/l
0.07
432
3623
158
1081
1.54
5.52
1.5
1.4
—
—
—
0
0
121
778
1.62
5.52
4.2
3.3
7.34
7.35
ph
0.17
86
561
423
3465
1.35
5.45
3.0
3.0
26.47
27.46
u/l
0.36
400
3302
1046
9909
1.67
5.42
16.3
12.4
3.91
3.91
mmol/l
0.21
1021
9669
191
1366
1.48
5.40
2.9
2.7
7.04
4.39
e6/l
0.86
89
595
1044
9890
1.65
5.35
16.1
12.3
139.46
139.60
mmol/l
1.17
1024
9674
152
1041
1.53
5.29
2.7
2.2
4274.56
7329.79
u/l
0.73
45
445
314
2470
1.37
5.20
3.1
2.8
0.34
0.39
e6/l
0.25
236
1717
157
1088
1.51
5.17
2.0
2.4
5.80
5.56
umol/l
0.09
132
925
140
950
1.54
5.08
8.3
5.4
104.76
104.49
mmol/l
0.30
140
950
204
1497
1.44
5.03
3.5
3.1
254.79
219.20
ng/l
0.07
106
869
231
1736
1.41
4.99
1.4
1.4
551.22
573.69
titre
0.05
41
374
90
562
1.65
4.63
2.9
2.7
68.41
75.20
e9/l
1.13
68
390
104
674
1.60
4.61
3.9
3.0
1.81
1.88
mmol/l
0.07
87
588
691
6172
1.30
4.48
3.8
3.2
74.02
69.52
ug/l
0.32
652
5869
200
1503
1.40
4.29
2.8
2.5
1.24
1.42
e6/l
0.16
102
726
18
61
2.98
4.29
3.7
2.8
16.17
13.64
index
0.27
12
39
13
30
4.37
4.13
2.1
2.3
14.65
15.67
umol/l
0.10
13
30
426
3600
1.29
4.12
4.3
3.5
85.95
75.59
e6/l
0.14
311
2270
636
5655
1.28
4.11
4.2
3.5
0.02
8.11
estimate
1.82
132
1205
799
7326
1.30
4.00
3.5
2.9
36.06
34.09
u/l
0.40
763
7027
628
5589
1.27
3.96
4.2
3.4
0.01
0.00
estimate
0.35
132
1181
290
2337
1.32
3.96
4.0
3.4
94.93
97.16
%
0.83
284
2281
236
1845
1.35
3.96
2.4
2.7
997.89
719.81
ng/l
0.37
186
1529
48
262
1.87
3.95
1.3
1.3
307.50
317.06
ug/g
0.09
24
147
110
750
1.52
3.93
2.4
2.2
0.22
0.22
g/l
0.07
101
707
637
5689
1.27
3.86
4.3
3.5
0.00
0.01
estimate
1.22
128
1157
181
1362
1.39
3.85
1.3
1.2
—
—
—
0
0
95
634
1.54
3.75
3.1
2.2
0.20
0.37
e6/l
0.89
90
597
94
626
1.55
3.74
1.3
1.2
—
—
—
0
0
112
777
1.49
3.69
2.6
2.8
1.70
1.82
%
0.73
103
702
491
4270
1.26
3.65
3.8
3.3
0.03
0.05
estimate
0.33
101
968
296
2419
1.30
3.62
3.7
3.5
1.02
2.29
kg/l
0.80
191
1589
160
1192
1.40
3.61
1.8
1.9
29.08
29.03
s
0.04
154
1150
41
220
1.90
3.58
3.0
2.6
1.76
1.52
index
0.14
21
114
108
750
1.49
3.55
7.7
7.1
7.43
7.42
ph
1.56
51
416
101
693
1.50
3.52
4.1
3.1
7.38
7.38
ph
0.10
50
392
513
4499
1.25
3.51
3.7
3.1
6.26
6.26
ph
0.02
299
2566
206
1606
1.34
3.50
1.7
1.5
—
—
—
0
0
1092
10592
1.72
3.48
18.3
14.4
65.99
66.60
umol/l
0.37
1080
10469
89
599
1.53
3.40
1.7
2.0
—
—
—
0
0
366
3097
1.27
3.37
1.4
1.3
1.68
1.71
u/ml
0.01
104
857
107
751
1.47
3.34
7.9
7.1
4.88
5.11
kpa
1.96
101
725
107
751
1.47
3.34
7.8
7.1
12.41
13.34
kpa
1.53
99
725
94
643
1.50
3.33
1.7
1.9
—
—
—
0
0
94
645
1.50
3.29
1.7
1.9
—
—
—
0
0
105
739
1.46
3.24
7.9
7.1
-0.12
1.00
mmol/l
1.87
84
604
93
639
1.50
3.23
1.7
1.9
—
—
—
0
0
938
8872
1.32
3.22
5.2
4.9
14.34
14.41
pmol/l
0.39
873
8364
111
791
1.45
3.21
2.2
3.1
11.39
10.36
g/l
0.73
105
739
311
2608
1.26
3.04
1.4
1.5
2.07
2.15
g/l
0.43
198
1684
132
981
1.39
3.03
6.0
4.7
1.02
1.04
mmol/l
0.52
124
902
93
649
1.47
3.01
1.7
1.9
—
—
—
0
0
38
212
1.82
2.99
1.1
1.2
—
—
—
0
0
67
438
1.56
2.94
1.2
1.2
—
—
—
0
0
1131
11132
2.82
2.94
24.7
18.9
273.94
267.96
e9/l
2.49
1119
10964
1090
10605
1.62
2.92
14.6
10.8
—
—
—
0
0
1131
11134
2.80
2.90
24.6
18.8
30.07
30.07
pg
0.02
1125
11051
1131
11134
2.80
2.90
24.6
18.8
90.41
90.45
fl
0.10
1125
11051
1131
11135
2.79
2.88
25.2
19.0
39.97
39.84
%
0.60
1125
11051
1131
11136
2.78
2.86
24.7
18.8
4.45
4.44
e12/l
0.11
1116
10944
1131
11137
2.77
2.84
24.8
18.9
6.96
6.71
e9/l
2.52
1118
10938
167
1302
1.33
2.84
2.9
2.8
4.20
4.66
e9/l
0.66
142
1190
38
217
1.78
2.79
1.2
1.2
245.70
246.57
u/ml
0.01
23
138
40
232
1.75
2.79
3.4
3.5
58.48
58.86
%
0.07
40
232
45
270
1.69
2.79
4.0
3.1
—
—
—
0
0
12
39
3.10
2.77
4.7
3.1
0.92
0.74
index
0.35
12
39
172
1352
1.32
2.76
1.2
1.2
—
—
—
0
0
33
181
1.85
2.76
3.9
3.7
4.06
4.18
e9/l
0.18
33
181
1131
11143
2.71
2.72
24.9
19.0
132.99
132.77
g/l
0.27
1125
11059
90
638
1.45
2.71
8.3
7.6
96.57
96.40
%
0.17
85
618
382
3322
1.23
2.64
2.2
2.1
—
—
—
0
0
18
80
2.27
2.61
1.1
1.3
—
—
—
0
0
118
886
1.37
2.57
1.5
1.3
102.64
196.60
u/ml
1.71
110
821
61
404
1.54
2.56
4.0
3.1
7.40
7.42
ph
2.55
49
343
13
50
2.62
2.53
2.2
2.7
—
—
—
0
0
351
3037
1.22
2.53
5.4
5.8
—
—
—
0
0
128
979
1.35
2.49
2.6
2.0
0.00
0.04
estimate
1.05
24
225
1026
9908
1.35
2.46
6.4
5.9
1.67
1.77
mu/l
2.95
968
9458
283
2401
1.24
2.45
1.4
1.3
25.00
26.63
iu/ml
0.09
81
721
268
2261
1.24
2.44
2.3
2.3
298.42
299.20
umol/l
0.05
233
2030
107
798
1.38
2.44
2.6
2.4
18.48
21.87
au/ml
0.26
19
103
51
331
1.57
2.36
1.4
1.3
—
—
—
0
0
366
3200
1.21
2.35
3.3
2.8
0.10
0.02
estimate
0.39
98
973
34
199
1.73
2.34
3.7
3.7
29.96
27.17
mg/l
0.14
28
171
34
199
1.73
2.34
3.7
3.7
29.89
35.59
mg/l
0.60
28
172
32
184
1.76
2.34
1.3
1.3
151.40
167.03
au/ml
—
5
52
944
9037
1.26
2.27
5.7
5.0
38.14
37.35
mmol/mol
1.87
886
8610
33
194
1.72
2.24
1.4
1.3
—
—
—
0
0
513
4645
1.19
2.23
11.5
9.7
0.00
0.00
e9/l
0.65
416
3857
30
172
1.76
2.22
1.1
1.2
3.60
3121.97
iu/ml
—
5
42
43
274
1.59
2.17
2.1
2.5
—
—
—
0
0
136
1073
1.30
2.15
1.4
1.5
—
—
—
0
0
29
168
1.75
2.09
3.8
3.8
1.75
2.64
ratio
0.59
18
92
46
301
1.55
2.08
1.2
1.3
—
—
—
0
0
5
10
5.02
2.07
1.4
2.3
29.50
24.20
mg/l
—
5
10
150
1209
1.28
2.02
1.5
1.4
—
—
—
0
0
35
217
1.63
1.99
1.3
1.2
—
6.66
—
0
5
23
127
1.83
1.95
4.0
4.5
—
—
—
0
0
106
820
1.32
1.95
4.6
4.4
1.07
0.70
%
0.51
29
193
25
143
1.77
1.90
3.5
2.8
2.46
2.27
mmol/l
0.09
14
92
63
452
1.42
1.85
2.4
1.8
—
—
—
0
0
13
59
2.22
1.84
2.2
2.7
—
—
—
0
0
211
1788
1.22
1.83
2.1
2.4
2.43
2.43
mmol/l
0.19
185
1609
323
2852
1.18
1.81
1.8
1.8
—
—
—
0
0
105
821
1.31
1.80
5.6
4.7
0.20
0.11
%
0.31
25
173
107
839
1.30
1.80
5.6
4.9
0.08
0.62
%
0.55
26
159
13
60
2.18
1.78
2.3
1.6
42.21
37.72
%
—
8
32
37
241
1.55
1.75
1.1
1.1
2.32
14.79
au/ml
—
10
64
22
125
1.77
1.72
1.1
1.2
0.17
0.33
nmol/l
0.46
17
85
1081
10593
1.39
1.72
12.4
10.3
23.52
23.23
u/l
0.29
1063
10331
15
75
2.01
1.70
1.0
1.1
1470.93
1530.29
miu/ml
0.08
15
75
75
567
1.35
1.64
2.9
2.7
67.51
67.52
g/l
0.00
68
536
256
2234
1.19
1.63
1.4
1.3
5.76
11.17
u/ml
1.03
114
920
61
447
1.39
1.62
1.9
2.1
3.73
5.13
ug/l
0.82
49
405
107
853
1.28
1.61
5.5
4.6
0.85
1.04
%
0.38
27
207
7
26
2.70
1.58
4.1
3.2
0.59
0.63
mmol/l
—
7
26
43
297
1.47
1.57
1.2
1.2
—
1083.33
—
0
18
14
71
1.98
1.54
1.1
1.2
—
188.00
—
0
15
81
626
1.32
1.54
1.4
1.9
1.40
1.40
g/l
0.01
73
585
300
2670
1.17
1.51
3.9
3.5
7.40
7.40
ph
0.29
207
1892
15
81
1.86
1.40
3.9
2.3
—
—
—
0
0
100
806
1.26
1.40
1.2
1.2
—
—
—
0
0
10
46
2.18
1.40
2.4
2.3
—
—
—
0
0
334
3013
1.15
1.40
4.3
3.6
0.00
0.00
estimate
1.08
124
1153
301
2697
1.16
1.38
4.8
4.3
—
—
—
0
0
35
240
1.47
1.36
1.8
1.7
387.44
363.42
mu/l
0.10
27
196
0
39
0.00
1.34
0.0
2.1
—
501.69
—
0
29
41
292
1.42
1.32
4.7
2.9
163.94
317.27
mg/l
1.63
17
106
126
1051
1.22
1.31
1.3
1.2
—
—
—
0
0
61
465
1.33
1.31
2.8
2.0
0.14
0.01
estimate
0.43
22
176
66
509
1.31
1.31
1.2
1.3
0.22
1.05
u/ml
—
6
35
6
24
2.51
1.30
2.0
1.2
—
—
—
0
0
22
137
1.62
1.30
1.2
1.4
—
—
—
0
0
24
153
1.58
1.29
4.1
2.8
—
—
—
0
0
20
122
1.65
1.28
1.3
1.2
—
—
nmol/l
—
0
0
11
55
2.01
1.27
1.1
1.6
—
85.63
%
—
0
8
970
9437
1.19
1.27
4.7
4.2
5.72
5.63
mmol/l
1.21
905
8887
61
468
1.32
1.26
2.7
2.2
—
—
—
0
0
311
2811
1.15
1.26
3.5
3.2
7.23
7.27
mmol/l
0.05
262
2444
43
312
1.39
1.26
1.8
2.3
5.46
4.94
umol/l
0.17
34
230
67
850
0.78
1.23
1.6
1.5
63.43
59.69
ug/l
0.26
51
721
12
63
1.91
1.23
1.8
2.0
1.22
1.20
mmol/l
0.69
12
63
90
730
1.25
1.22
2.1
1.9
—
—
—
0
0
12
64
1.88
1.18
1.8
2.0
4.05
3.85
mmol/l
1.01
12
64
12
64
1.88
1.18
1.8
2.0
106.50
106.27
mmol/l
0.06
12
64
211
1864
1.16
1.17
1.7
1.5
—
—
—
0
0
951
9255
1.17
1.15
4.0
3.7
1.25
1.19
mmol/l
2.03
892
8750
17
103
1.66
1.13
1.1
1.1
110.71
115.61
pmol/l
0.15
17
103
61
477
1.29
1.12
1.5
1.6
11.48
11.50
u/ml
0.00
13
125
7
30
2.34
1.12
1.1
1.1
14.29
40.82
iu/ml
—
7
30
100
830
1.22
1.12
2.1
3.0
25.46
60.21
u/ml
1.43
100
803
113
950
1.21
1.11
2.5
2.3
38.31
37.75
u/l
0.02
94
790
59
460
1.30
1.11
3.8
2.5
1.01
1.02
ratio
0.56
54
418
36
260
1.40
1.10
1.3
1.1
—
—
—
0
0
36
260
1.40
1.10
1.1
1.5
313.23
1406.39
e6/l
0.53
26
203
36
260
1.40
1.10
1.3
1.1
—
—
—
0
0
8
41
1.96
1.09
1.6
1.7
97.39
103.92
ng/l
—
8
41
134
1151
1.19
1.06
1.4
1.4
29.14
24.14
iu/l
0.88
124
1013
97
808
1.22
1.06
1.4
1.4
—
—
—
0
0
52
402
1.31
1.05
1.9
1.8
20.57
20.04
s
0.59
44
353
392
3637
1.12
1.03
1.8
1.7
—
—
—
0
0
13
75
1.74
1.03
1.1
1.0
—
—
—
0
0
9
49
1.84
0.98
2.3
4.3
8.15
69.03
mg/l
—
9
31
0
29
0.00
0.98
0.0
1.8
—
—
—
0
0
10
54
1.86
0.96
3.0
3.1
—
—
—
0
0
32
234
1.38
0.94
1.1
1.4
—
—
—
0
0
177
1571
1.15
0.94
2.2
1.9
—
—
—
0
0
6
27
2.23
0.93
1.0
1.2
—
—
—
0
0
107
913
1.19
0.93
4.0
3.4
—
—
—
0
0
27
192
1.42
0.93
1.9
1.7
7254.88
12221.55
e6/l
0.48
17
134
55
438
1.27
0.91
2.1
1.5
0.24
0.29
mg/l
0.33
22
176
25
176
1.43
0.91
1.2
1.6
0.32
0.62
g/l
2.23
19
142
14
86
1.64
0.91
2.3
2.0
88.76
91.18
%
0.96
14
86
24
168
1.44
0.90
2.1
2.3
—
—
—
0
0
135
1180
1.16
0.89
1.2
1.2
154.59
155.75
u/ml
0.01
55
485
51
406
1.27
0.86
2.2
2.2
—
—
—
0
0
34
256
1.34
0.85
1.1
1.4
4.50
13.90
e6/l
1.29
24
187
54
667
0.80
0.85
1.6
1.6
—
—
—
0
0
29
213
1.37
0.85
1.0
1.1
—
—
—
0
0
78
924
0.83
0.83
1.6
1.7
—
—
—
0
0
66
545
1.22
0.82
1.0
1.1
—
—
—
0
0
12
189
0.63
0.81
1.3
1.5
6.59
6.87
mmol/l
0.13
12
171
8
47
1.71
0.80
1.0
1.9
69.50
93.73
nmol/24h
—
8
47
11
66
1.67
0.79
1.1
1.0
—
—
—
0
0
26
191
1.37
0.77
1.0
1.0
—
—
—
0
0
27
200
1.36
0.76
2.4
2.3
7.87
6.91
pmol/l
0.16
27
200
442
4182
1.09
0.76
1.9
1.8
1.43
1.30
mmol/l
2.69
379
3661
133
1497
0.87
0.76
1.6
1.6
947.34
1024.17
mu/l
0.50
103
1268
15
99
1.52
0.75
1.1
1.9
32.53
31.43
pg
0.46
15
99
15
220
0.68
0.75
1.1
1.1
2.14
2.23
eliau/ml
—
7
114
5
24
2.09
0.74
1.0
1.0
4.40
5.55
mg/g
—
5
24
1002
9853
1.14
0.74
4.7
4.3
1.50
1.57
mmol/l
5.38
944
9364
46
370
1.25
0.74
1.5
1.4
80.48
121.84
pmol/l
0.57
46
362
15
100
1.51
0.73
1.0
1.0
—
—
—
0
0
53
639
0.82
0.70
1.6
1.5
1.22
1.28
mm
0.29
33
465
16
110
1.46
0.68
1.1
1.3
3.19
2.98
g/l
0.18
11
81
16
110
1.46
0.68
1.1
1.3
0.39
0.36
g/l
0.13
11
80
1004
9884
1.13
0.68
4.7
4.3
4.80
4.82
mmol/l
0.38
953
9436
16
111
1.45
0.66
1.1
1.3
6.30
6.75
g/l
0.21
11
81
22
163
1.36
0.64
5.6
3.1
—
—
—
0
0
13
88
1.48
0.60
1.2
1.2
0.52
0.63
ratio
—
5
47
55
649
0.84
0.60
1.6
1.5
—
—
—
0
0
15
105
1.43
0.60
2.5
1.9
1.97
1.71
mmol/l
0.55
15
105
24
183
1.32
0.60
1.1
1.1
—
—
—
0
0
83
726
1.15
0.59
3.3
4.4
4.49
9.71
ug/l
1.75
55
569
19
140
1.36
0.58
1.7
1.5
—
—
—
0
0
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
6
39
1.54
0.53
3.5
1.8
—
—
—
0
0
31
250
1.25
0.53
3.6
2.2
10.93
10.26
g/l
0.18
26
233
14
100
1.40
0.52
1.9
1.9
0.71
0.97
%
—
9
53
15
109
1.38
0.51
1.1
1.4
—
—
—
0
0
12
84
1.43
0.49
2.8
2.5
—
—
—
0
0
470
4529
1.06
0.47
2.6
2.7
—
—
—
0
0
19
146
1.31
0.47
1.7
1.8
—
—
—
0
0
23
182
1.27
0.46
1.1
1.2
—
—
—
0
0
34
282
1.21
0.46
9.1
7.9
—
—
—
0
0
911
8971
1.08
0.45
18.9
14.9
13.41
13.38
%
0.31
904
8847
15
112
1.34
0.44
1.4
2.0
6.73
42.41
u/ml
0.55
15
112
18
139
1.30
0.44
2.3
2.1
—
—
—
0
0
1008
9969
1.10
0.43
5.1
4.8
2.88
2.84
mmol/l
0.87
947
9489
31
371
0.83
0.43
1.7
1.5
0.69
0.45
nmol/l
0.32
26
304
5
31
1.62
0.43
1.0
1.1
6.98
5.89
nmol/l
—
5
31
34
285
1.20
0.43
2.6
2.0
1.88
1.43
g/l
1.17
29
247
17
131
1.30
0.42
2.9
1.6
—
—
—
0
0
59
520
1.14
0.41
1.9
2.2
3.13
8.07
iu/ml
2.03
16
127
8
58
1.38
0.41
1.0
1.1
—
—
—
0
0
25
204
1.23
0.41
1.2
1.2
3.40
4.93
u/ml
—
10
81
64
569
1.13
0.40
1.1
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
2.2
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
1.0
—
0.18
—
0
11
15
115
1.31
0.39
1.1
1.3
0.09
1.11
u/ml
—
6
58
255
2426
1.07
0.38
4.6
4.0
9.13
7.56
mg/mmol
0.21
145
1432
36
308
1.17
0.38
1.4
1.2
—
—
—
0
0
246
2341
1.06
0.37
1.9
1.8
—
—
—
0
0
13
169
0.77
0.37
1.1
1.4
—
86.33
—
0
12
162
1522
1.08
0.35
1.8
1.8
3.32
3.24
ratio
0.36
117
1118
31
264
1.18
0.35
2.3
2.2
10.92
10.80
mg/l
0.06
31
249
58
647
0.89
0.35
1.4
1.4
177.80
241.40
miu/ml
1.03
29
329
35
302
1.16
0.34
1.5
1.4
19.83
22.24
u/l
0.21
29
262
12
91
1.32
0.34
1.0
1.2
—
—
—
0
0
47
416
1.14
0.33
1.2
1.2
—
—
—
0
0
72
655
1.11
0.33
4.7
3.4
80.95
73.93
ng/l
0.41
64
581
250
2393
1.06
0.32
3.8
3.4
40.30
37.50
mg/l
0.08
145
1441
14
110
1.28
0.31
1.1
1.1
19.49
12.14
u/ml
—
7
59
36
314
1.15
0.31
1.2
1.2
—
—
—
0
0
7
55
1.27
0.30
3.7
2.8
497.86
885.76
u/ml
—
7
55
10
130
0.77
0.29
1.0
1.1
—
—
—
0
0
7
56
1.25
0.29
1.1
1.5
—
—
—
0
0
8
106
0.75
0.29
1.5
1.1
—
—
—
0
0
19
158
1.21
0.28
1.2
1.4
24.88
34.99
nmol/l
1.20
19
139
8
63
1.27
0.27
1.5
1.4
65.75
70.03
umol/l
—
8
63
9
121
0.74
0.27
1.1
1.3
—
—
—
0
0
9
121
0.74
0.27
1.1
1.3
—
—
—
0
0
9
121
0.74
0.27
1.1
1.3
—
—
—
0
0
9
121
0.74
0.27
1.1
1.3
—
—
—
0
0
23
196
1.18
0.27
1.3
1.2
—
—
—
0
0
47
424
1.11
0.26
1.5
1.3
16.35
12.13
u/l
0.70
41
348
37
415
0.89
0.26
1.9
2.3
3.29
4.08
iu/l
0.50
12
189
5
71
0.70
0.26
2.0
2.1
52.52
45.57
%
—
5
71
15
124
1.21
0.24
1.1
1.4
—
—
—
0
0
17
201
0.84
0.24
1.6
1.7
8.06
7.58
mmol/l
0.55
17
192
0
11
0.00
0.21
0.0
7.9
—
5.05
—
0
11
0
11
0.00
0.21
0.0
1.0
—
0.09
—
0
6
0
11
0.00
0.21
0.0
3.2
—
6.92
—
0
11
94
887
1.07
0.21
2.5
2.2
6.27
6.16
ph
0.51
60
580
5
43
1.16
0.21
1.4
1.6
126.80
134.63
nmol/l
—
5
43
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
41
374
1.10
0.20
1.8
1.3
2.28
3.51
ug/l
1.70
36
344
9
114
0.79
0.20
1.4
1.1
—
—
—
0
0
7
58
1.21
0.18
2.0
2.2
1339.29
1186.16
mg
—
7
58
80
756
1.06
0.18
1.7
1.7
385.47
304.30
mu/l
0.84
71
678
7
62
1.13
0.17
1.1
1.2
—
—
—
0
0
7
63
1.11
0.17
2.0
2.0
—
—
—
0
0
43
399
1.08
0.16
1.4
1.3
—
—
—
0
0
8
73
1.10
0.15
1.0
1.5
—
—
—
0
0
127
1318
0.96
0.15
1.3
1.3
—
—
—
0
0
17
153
1.11
0.11
1.2
1.2
—
—
—
0
0
120
1168
1.03
0.09
1.6
1.6
3.39
3.41
mmol/l
0.06
74
775
5
46
1.09
0.09
1.4
1.5
102.60
154.94
mmol/24h
—
5
46
5
61
0.82
0.08
2.0
2.5
286.00
506.18
e6/l
—
5
49
32
303
1.06
0.08
1.1
1.1
1.04
1.72
u/ml
0.56
13
139
7
82
0.85
0.07
2.0
2.4
736.57
1380.03
e6/l
—
7
72
7
83
0.84
0.07
1.6
1.5
4.26
6.96
ug/l
—
7
70
9
88
1.02
0.07
1.1
1.2
—
—
—
0
0
14
128
1.09
0.06
2.0
3.7
17.29
50.69
u/ml
1.56
14
128
26
274
0.95
0.06
1.0
1.0
1.24
3.68
u/ml
1.14
11
130
73
714
1.02
0.04
4.4
3.1
1.23
1.23
mmol/l
0.42
58
607
53
544
0.97
0.04
1.1
1.1
0.89
0.87
g/l
0.36
53
544
15
160
0.94
0.04
1.9
2.2
—
—
—
0
0
13
121
1.08
0.03
1.2
1.5
—
—
—
0
0
36
349
1.03
0.03
2.2
1.9
—
—
—
0
0
31
320
0.97
0.03
1.1
1.1
2.61
4.44
u/ml
—
10
165
52
531
0.98
0.03
1.1
1.1
1.56
1.60
g/l
0.71
52
531
23
236
0.97
0.00
1.0
1.0
0.04
0.08
u/ml
—
6
66
11
106
1.04
0.00
1.0
1.0
0.21
4.79
u/ml
—
5
35
20
196
1.02
0.00
1.8
2.0
6.13
5.12
mmol/24h
0.57
14
180
13
128
1.02
0.00
1.2
1.1
—
—
—
0
0
30
302
0.99
0.00
1.1
1.1
0.38
0.89
u/ml
—
7
119
36
361
1.00
0.00
1.1
1.1
1.71
3.03
u/ml
0.56
15
176
14
137
1.02
0.00
1.2
1.6
22.99
23.41
ng/l
0.02
14
137
88
875
1.01
0.00
3.7
3.7
4.43
4.56
pmol/l
0.53
79
791
25
255
0.98
0.00
1.1
1.1
3.04
5.35
u/ml
0.37
11
109
0
7
0.00
0.00
0.0
3.1
—
34.86
—
0
7
0
7
0.00
0.00
0.0
1.4
—
212.29
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
62
0.97
-0.00
3.3
3.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
53
0.94
-0.00
1.0
1.0
963.20
784.30
ng/l
—
5
40
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.2
—
331.50
—
0
6
5
52
0.96
-0.00
1.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
6
65
0.92
-0.00
2.2
2.5
189.67
204.86
e6/l
—
6
56
0
6
0.00
-0.00
0.0
1.0
—
1.01
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
74
0.95
-0.00
1.0
1.2
6.14
7.80
mm/h
—
7
74
9
93
0.97
-0.00
1.2
1.2
—
—
—
0
0
8
85
0.94
-0.00
1.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
0.05
—
0
9
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
51
0.98
-0.00
1.0
1.2
121.28
156.66
iu/ml
—
5
51
5
52
0.96
-0.00
2.4
1.1
5.40
6.13
mmol/l
—
5
46
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
66
0.91
-0.00
2.3
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint N14_BARTHOABSCESS and mortality.

Females

Parameter HR [95% CI] p-value
N14_BARTHOABSCESS 1.431 [1.2, 1.7] < 0.001
Birth year 0.993 [0.98, 1.0] 0.115

During the follow-up period (1.1.1998 — 31.12.2019), 231 out of 5332 females with N14_BARTHOABSCESS died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have N14_BARTHOABSCESS.

N-year risk Females Males
1 0.117% No data
5 0.766% No data
10 1.922% No data
15 3.835% No data
20 6.712% No data

Relationships between endpoints

↥

Index endpoint: N14_BARTHOABSCESS – Abscess of Bartholin gland

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data